cached image

Ralph Martins, PhD - Publications

Affiliations: 
University of Western Australia, Crawley, Western Australia, Australia 
Website:
http://www.sebhs.ecu.edu.au/staff/cv/ralph_martins.php

464 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Pedrini S, Chatterjee P, Nakamura A, Tegg M, Hone E, Rainey-Smith SR, Rowe CC, Dore V, Villemagne VL, Ames D, Kaneko N, Gardener SL, Taddei K, Fernando B, Martins I, ... ... Martins RN, et al. The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults. Frontiers in Aging Neuroscience. 14: 771214. PMID 35418852 DOI: 10.3389/fnagi.2022.771214  0.493
2022 Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Krishnadas N, Bourgeat P, Huang K, Burnham S, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, et al. Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12307. PMID 35415202 DOI: 10.1002/dad2.12307  0.529
2022 Woodfield A, Porter T, Gilani I, Noordin S, Li QX, Collins S, Martins RN, Maruff P, Masters CL, Rowe CC, Villemagne VL, Dore V, Newsholme P, Laws SM, Verdile G. Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels. Neurobiology of Aging. 114: 38-48. PMID 35381406 DOI: 10.1016/j.neurobiolaging.2022.03.004  0.48
2022 Dharmaraj GL, Arigo FD, Young KA, Martins R, Mancera RL, Bharadwaj P. Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity. Journal of Alzheimer's Disease : Jad. PMID 35275530 DOI: 10.3233/JAD-215339  0.3
2022 Rosenich E, Bransby L, Yassi N, Fripp J, Laws SM, Martins RN, Fowler C, Rainey-Smith SR, Rowe CC, Masters CL, Maruff P, Lim YY. Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in AB- and AB+ Older Adults. Neurology. PMID 35169009 DOI: 10.1212/WNL.0000000000200118  0.419
2022 Guévremont D, Tsui H, Knight R, Fowler CJ, Masters CL, Martins RN, Abraham WC, Tate WP, Cutfield NJ, Williams JM. Plasma microRNA vary in association with the progression of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12251. PMID 35141392 DOI: 10.1002/dad2.12251  0.451
2022 Laffoon SB, Doecke JD, Roberts AM, Vance JA, Reeves BD, Pertile KK, Rumble RL, Fowler CJ, Trounson B, Ames D, Martins R, Bush AI, Masters CL, Grieco PA, Dratz EA, et al. Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. Proteome Science. 20: 2. PMID 35081972 DOI: 10.1186/s12953-021-00185-9  0.552
2022 Wang T, Huynh K, Giles C, Mellett NA, Duong T, Nguyen A, Lim WLF, Smith AA, Olshansky G, Cadby G, Hung J, Hui J, Beilby J, Watts GF, Chatterjee P, ... ... Martins RN, et al. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35077012 DOI: 10.1002/alz.12538  0.562
2022 Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Martins R, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6  0.476
2021 Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Leslie SM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. PMID 34906975 DOI: 10.1212/WNL.0000000000013211  0.475
2021 Gardener SL, Rainey-Smith SR, Villemagne VL, Fripp J, Doré V, Bourgeat P, Taddei K, Fowler C, Masters CL, Maruff P, Rowe CC, Ames D, Martins RN. Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study. Frontiers in Aging Neuroscience. 13: 744872. PMID 34867277 DOI: 10.3389/fnagi.2021.744872  0.501
2021 Buckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, ... ... Martins R, et al. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34854530 DOI: 10.1002/alz.12505  0.428
2021 Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN. Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease. Nutrients. 13. PMID 34836000 DOI: 10.3390/nu13113744  0.535
2021 Rezaee N, Fernando WMADB, Hone E, Sohrabi HR, Johnson SK, Gunzburg S, Martins RN. Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer's Disease: A Review Article. Frontiers in Aging Neuroscience. 13: 729949. PMID 34690742 DOI: 10.3389/fnagi.2021.729949  0.324
2021 Tarawneh HY, Mulders WHAM, Sohrabi HR, Martins RN, Jayakody DMP. Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies. Journal of Alzheimer's Disease : Jad. 84: 419-448. PMID 34569950 DOI: 10.3233/JAD-210556  0.335
2021 Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simrén J, Vanmechelen E, Armstrong NJ, Hone E, Asih PR, Taddei K, Doré V, Villemagne VL, ... ... Martins RN, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34494715 DOI: 10.1002/alz.12447  0.45
2021 Fowler C, Rainey-Smith SR, Bird S, Bomke J, Bourgeat P, Brown BM, Burnham SC, Bush AI, Chadunow C, Collins S, Doecke J, Doré V, Ellis KA, Evered L, Fazlollahi A, ... ... Martins RN, et al. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 443-468. PMID 34368630 DOI: 10.3233/ADR-210005  0.629
2021 Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, ... ... Martins RN, et al. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 20: 615-626. PMID 34302786 DOI: 10.1016/S1474-4422(21)00139-3  0.45
2021 Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, ... ... Martins RN, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197  0.44
2021 Gardener SL, Weinborn M, Sohrabi HR, Doecke JD, Bourgeat P, Rainey-Smith SR, Shen KK, Fripp J, Taddei K, Maruff P, Salvado O, Savage G, Ames D, Masters CL, Rowe CC, ... Martins RN, et al. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults. Journal of Alzheimer's Disease : Jad. 81: 1039-1052. PMID 33935071 DOI: 10.3233/JAD-201243  0.383
2021 Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM. Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. Alzheimer's Research & Therapy. 13: 79. PMID 33863377 DOI: 10.1186/s13195-021-00812-9  0.362
2021 Chatterjee P, Tegg M, Pedrini S, Fagan AM, Xiong C, Singh AK, Taddei K, Gardener S, Masters CL, Schofield PR, Multhaup G, Benzinger TLS, Morris JC, Bateman RJ, Greenberg SM, ... ... Martins RN, et al. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation. International Journal of Molecular Sciences. 22. PMID 33805778 DOI: 10.3390/ijms22062931  0.425
2021 Fernandez S, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. Is Associated with Amyloid-β and ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports. 5: 111-120. PMID 33782664 DOI: 10.3233/ADR-200246  0.649
2021 Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, ... ... Martins RN, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112  0.341
2021 Moussavi Nik SH, Porter T, Newman M, Bartlett B, Khan I, Sabale M, Eccles M, Woodfield A, Groth D, Dore V, Villemagne VL, Masters CL, Martins RN, Laws SM, Lardelli M, et al. Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration. Journal of Alzheimer's Disease : Jad. PMID 33720885 DOI: 10.3233/JAD-201133  0.728
2021 Tan S, Porter T, Bucks RS, Weinborn M, Milicic L, Brown A, Rainey-Smith SR, Taddei K, Ames D, Masters CL, Maruff P, Savage G, Rowe CC, Villemagne VL, Brown B, ... ... Martins RN, et al. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. Hormones and Behavior. 131: 104966. PMID 33714752 DOI: 10.1016/j.yhbeh.2021.104966  0.397
2021 Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease. Translational Psychiatry. 11: 27. PMID 33431793 DOI: 10.1038/s41398-020-01137-1  0.349
2020 Chatterjee P, Fagan AM, Xiong C, McKay M, Bhatnagar A, Wu Y, Singh AK, Taddei K, Martins I, Gardener SL, Molloy MP, Multhaup G, Masters CL, Schofield PR, Benzinger TLS, ... ... Martins RN, et al. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations. Journal of Alzheimer's Disease : Jad. PMID 33361604 DOI: 10.3233/JAD-201267  0.401
2020 Jayatunga DPW, Hone E, Bharadwaj P, Garg M, Verdile G, Guillemin GJ, Martins RN. Targeting Mitophagy in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33285629 DOI: 10.3233/JAD-191258  0.6
2020 van der Kall LM, Truong T, Burnham SC, Doré V, Mulligan RS, Bozinovski S, Lamb F, Bourgeat P, Fripp J, Schultz S, Lim YY, Laws SM, Ames D, Fowler C, Rainey-Smith SR, ... Martins RN, et al. Association of β-amyloid level, clinical progression and longitudinal cognitive change in normal older individuals. Neurology. PMID 33184233 DOI: 10.1212/WNL.0000000000011222  0.445
2020 Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith AAT, Olshansky G, Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL, ... ... Martins RN, et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Nature Communications. 11: 5698. PMID 33173055 DOI: 10.1038/s41467-020-19473-7  0.55
2020 Xia Y, Yassi N, Raniga P, Bourgeat P, Desmond P, Doecke J, Ames D, Laws SM, Fowler C, Rainey-Smith SR, Martins R, Maruff P, Villemagne VL, Masters CL, Rowe CC, et al. Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging. Journal of Alzheimer's Disease : Jad. PMID 32986666 DOI: 10.3233/JAD-200419  0.484
2020 Krishnan S, Shrestha Y, Jayatunga DPW, Rea S, Martins R, Bharadwaj P. Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease. International Journal of Molecular Sciences. 21. PMID 32937909 DOI: 10.3390/Ijms21186739  0.407
2020 Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing. Life (Basel, Switzerland). 10. PMID 32781776 DOI: 10.3390/Life10080141  0.526
2020 Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 32772959 DOI: 10.1017/S135561772000079X  0.443
2020 Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, et al. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition. Neurobiology of Aging. 95: 46-55. PMID 32750666 DOI: 10.1016/J.Neurobiolaging.2020.06.001  0.462
2020 Pedrini S, Hone E, Gupta VB, James I, Teimouri E, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Wenk MR, ... ... Martins RN, et al. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer's Disease : Jad. PMID 32741823 DOI: 10.3233/Jad-200291  0.706
2020 Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM, Calandri I, Caramelli P, Chen C, Chertkow H, Chew E, ... ... Martins R, et al. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32627328 DOI: 10.1002/Alz.12123  0.349
2020 Bharadwaj P, Solomon T, Sahoo BR, Ignasiak K, Gaskin S, Rowles J, Verdile G, Howard MJ, Bond CS, Ramamoorthy A, Martins RN, Newsholme P. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells. Scientific Reports. 10: 10356. PMID 32587390 DOI: 10.1038/S41598-020-66602-9  0.619
2020 Ashraf A, Ashton NJ, Chatterjee P, Goozee K, Shen K, Fripp J, Ames D, Rowe C, Masters CL, Villemagne V, Hye A, Martins RN, So PW. Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. Alzheimer's Research & Therapy. 12: 72. PMID 32517787 DOI: 10.1186/S13195-020-00634-1  0.499
2020 Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, Mellett NA, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Drew BG, Masters CL, Meikle PJ, ... Martins RN, et al. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32474467 DOI: 10.3233/Jad-191304  0.574
2020 Lim B, Li QX, Rowe C, Dhiman K, Gupta VB, Masters CL, Doecke JD, Martins RN, Collins S, Diamandis EP. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Neuroscience Letters. 135078. PMID 32450185 DOI: 10.1016/J.Neulet.2020.135078  0.478
2020 Bharadwaj P, Martins R. A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ and protect against cell death in yeast. Neural Regeneration Research. 15: 1931-1936. PMID 32246642 DOI: 10.4103/1673-5374.280318  0.365
2020 Doecke JD, Ward L, Burnham SC, Villemagne VL, Li QX, Collins S, Fowler CJ, Manuilova E, Widmann M, Rainey-Smith SR, Martins RN, Masters CL. Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging. Alzheimer's Research & Therapy. 12: 36. PMID 32234072 DOI: 10.1186/s13195-020-00595-5  0.445
2020 Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, ... ... Martins RN, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12005. PMID 32211500 DOI: 10.1002/Dad2.12005  0.609
2020 Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Martins RN, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z  0.44
2020 Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, Moseley MA, Thompson JW, John-Williams LS, Tenenbaum JD, Blach C, Chang R, Brinton RD, ... ... Martins R, et al. Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome. Nature Communications. 11: 1148. PMID 32123170 DOI: 10.1038/S41467-020-14959-W  0.393
2020 Lai MMY, Ames DJ, Cox KL, Ellis KA, Sharman MJR, Hepworth G, Desmond P, Cyarto EV, Szoeke C, Martins R, Masters CL, Lautenschlager NT. Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline. The Journal of Nutrition, Health & Aging. 24: 300-304. PMID 32115611 DOI: 10.1007/S12603-020-1333-4  0.32
2020 Teimouri E, Rainey-Smith SR, Bharadwaj P, Verdile G, Martins RN. Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change. Journal of Alzheimer's Disease : Jad. PMID 32083581 DOI: 10.3233/Jad-191033  0.624
2020 Bharadwaj P, Martins RN. PRKAG2 Gene Expression Is Elevated and its Protein Levels Are Associated with Increased Amyloid-β Accumulation in the Alzheimer's Disease Brain. Journal of Alzheimer's Disease : Jad. PMID 32039845 DOI: 10.3233/JAD-190948  0.306
2020 Lai MMY, Sharman MJ, Ames DJ, Ellis KA, Cox KL, Hepworth G, Desmond P, Cyarto EV, Martins RN, Masters CL, Lautenschlager NT. Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration. Journal of Alzheimer's Disease : Jad. PMID 32007955 DOI: 10.3233/JAD-190953  0.377
2020 Fernando WMADB, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WLF, Martins RN. Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage. Journal of Alzheimer's Disease : Jad. PMID 31958090 DOI: 10.3233/JAD-190120  0.357
2020 Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Martins RN, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010  0.376
2019 Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe C, Villemagne V, Salvado O, et al. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31884485 DOI: 10.3233/Jad-191028  0.525
2019 Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, ... ... Martins RN, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/J.Trci.2019.09.015  0.422
2019 Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Scientific Reports. 9: 17069. PMID 31745181 DOI: 10.1038/S41598-019-53604-5  0.555
2019 Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. The Journal of Prevention of Alzheimer's Disease. 6: 248-255. PMID 31686097 DOI: 10.14283/jpad.2019.25  0.468
2019 Chatterjee P, Zetterberg H, Goozee K, Lim CK, Jacobs KR, Ashton NJ, Hye A, Pedrini S, Sohrabi HR, Shah T, Asih PR, Dave P, Shen K, Taddei K, Lovejoy DB, ... ... Martins RN, et al. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease. Journal of Neuroinflammation. 16: 186. PMID 31601232 DOI: 10.1186/s12974-019-1567-4  0.329
2019 Mputhia Z, Hone E, Tripathi T, Sargeant T, Martins R, Bharadwaj P. Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules (Basel, Switzerland). 24. PMID 31527516 DOI: 10.3390/Molecules24183372  0.404
2019 Chatterjee P, Elmi M, Goozee K, Shah T, Sohrabi HR, Dias CB, Pedrini S, Shen K, Asih PR, Dave P, Taddei K, Vanderstichele H, Zetterberg H, Blennow K, Martins RN. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31424403 DOI: 10.3233/JAD-190533  0.357
2019 Schultz A, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Grand Moursel L, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, ... ... Martins R, et al. Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers. Annals of Neurology. PMID 31361916 DOI: 10.1002/Ana.25560  0.354
2019 Tripathi T, Kalita P, Martins R, Bharadwaj P. Autophagy Promotes Memory Formation. Acs Chemical Neuroscience. PMID 31244056 DOI: 10.1021/Acschemneuro.9B00317  0.349
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. val158met is not associated with Aβ-amyloid and ε4 related cognitive decline in cognitively normal older adults. Ibro Reports. 6: 147-152. PMID 31080907 DOI: 10.1016/J.Ibror.2019.05.001  0.68
2019 Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, ... ... Martins R, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Science Advances. 5: eaau7220. PMID 30775436 DOI: 10.1126/Sciadv.Aau7220  0.593
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 76: 162-165. PMID 30716541 DOI: 10.1016/J.Neurobiolaging.2018.12.014  0.705
2019 Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3  0.515
2019 Jayatunga DP, Gupta VB, Hone E, Verdile G, Garg ML, Martins RN. P1-098: OPTIMAL CONCENTRATIONS OF LUTEOLIN AND DHA TO EXHIBIT SYNERGISTIC EFFECTS AGAINST Aβ1-42 -INDUCED NEUROTOXICITY Alzheimer's & Dementia. 15: P271-P272. DOI: 10.1016/J.Jalz.2019.06.653  0.535
2019 Martins RN, Chatterjee P, Masters CL, Zetterberg H, Blennow K, Nakamura A, Yanagisawa K. PATIENT-RELATED PRE-ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS Alzheimer's & Dementia. 15: P185. DOI: 10.1016/J.Jalz.2019.06.4386  0.337
2018 Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, et al. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423. PMID 30620773 DOI: 10.3389/Fnagi.2018.00423  0.672
2018 Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, ... ... Martins RN, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Translational Psychiatry. 8: 238. PMID 30375373 DOI: 10.1038/S41398-018-0293-5  0.498
2018 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059  0.486
2018 Khan I, Krishnaswamy S, Sabale M, Groth D, Wijaya L, Morici M, Berger I, Schaffitzel C, Fraser PE, Martins RN, Verdile G. Efficient production of a mature and functional gamma secretase protease. Scientific Reports. 8: 12834. PMID 30150752 DOI: 10.1038/S41598-018-30788-W  0.599
2018 Chatterjee P, Goozee K, Lim CK, James I, Shen K, Jacobs KR, Sohrabi HR, Shah T, Asih PR, Dave P, ManYan C, Taddei K, Lovejoy DB, Chung R, Guillemin GJ, ... Martins RN, et al. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study. Scientific Reports. 8: 8008. PMID 29789640 DOI: 10.1038/s41598-018-25968-7  0.32
2018 Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, ... ... Martins RN, et al. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychological Assessment. PMID 29781669 DOI: 10.1037/pas0000565  0.47
2018 Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 29758940 DOI: 10.3233/JAD-170998  0.411
2018 Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... Martins RN, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838  0.463
2018 Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145  0.733
2018 Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years. Alzheimer Disease and Associated Disorders. PMID 29561277 DOI: 10.1097/WAD.0000000000000252  0.485
2018 Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Martins RN, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053  0.449
2018 Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, ... Martins RN, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational Psychiatry. 8: 47. PMID 29479071 DOI: 10.1038/s41398-018-0094-x  0.368
2018 Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 554: 249-254. PMID 29420472 DOI: 10.1038/Nature25456  0.449
2018 Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, et al. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports. 8: 2034. PMID 29391469 DOI: 10.1038/S41598-018-20513-Y  0.724
2018 Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, ... ... Martins RN, et al. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. Journal of Alzheimer's Disease : Jad. 61: 1589-1598. PMID 29376865 DOI: 10.3233/JAD-170742  0.437
2018 Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Jama Neurology. PMID 29356823 DOI: 10.1001/jamaneurol.2017.4325  0.47
2018 Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. Journal of Affective Disorders. 229: 269-274. PMID 29329059 DOI: 10.1016/j.jad.2017.12.101  0.459
2017 Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, et al. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 45-52. PMID 29560886 DOI: 10.1016/j.bpsc.2016.08.006  0.509
2017 Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, ... ... Martins R, et al. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. Journal of Alzheimer's Disease : Jad. PMID 29171991 DOI: 10.3233/Jad-170128  0.634
2017 Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/S41598-017-14020-9  0.608
2017 Mirzaei M, Gupta VB, Chick JM, Greco TM, Wu Y, Chitranshi N, Wall RV, Hone E, Deng L, Dheer Y, Abbasi M, Rezaeian M, Braidy N, You Y, Salekdeh GH, ... ... Martins R, et al. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Scientific Reports. 7: 12685. PMID 28978942 DOI: 10.1038/S41598-017-12858-7  0.339
2017 Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry. Journal of Ophthalmology. 2017: 7935406. PMID 28894607 DOI: 10.1155/2017/7935406  0.475
2017 Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, ... ... Martins RN, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Scientific Reports. 7: 9766. PMID 28852028 DOI: 10.1016/J.Jalz.2017.06.2000  0.691
2017 Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/J.Dadm.2017.05.006  0.445
2017 Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Martins RN, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268  0.432
2017 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. International Journal of Geriatric Psychiatry. PMID 28736899 DOI: 10.1002/Gps.4761  0.319
2017 Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. International Psychogeriatrics. 1-10. PMID 28720165 DOI: 10.1017/S1041610217001284  0.439
2017 Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, Dave P, ManYan C, Taddei K, Ayton SJ, Garg ML, Kwok JB, Bush AI, Chung R, Magnussen JS, ... Martins RN, et al. Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load. Molecular Psychiatry. PMID 28696433 DOI: 10.1038/Mp.2017.146  0.522
2017 Asih PR, Tegg ML, Sohrabi H, Carruthers M, Gandy SE, Saad F, Verdile G, Ittner LM, Martins RN. Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier. Journal of Alzheimer's Disease : Jad. PMID 28655134 DOI: 10.3233/Jad-161259  0.535
2017 Binosha FWMAD, Somaratne G, Williams S, Goozee KG, Singh H, Martins RN. Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention? Journal of Alzheimer's Disease : Jad. PMID 28582855 DOI: 10.3233/Jad-161200  0.377
2017 Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. Journal of Alzheimer's Disease : Jad. PMID 28550258 DOI: 10.3233/JAD-170072  0.501
2017 Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003  0.605
2017 Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, ... ... Martins RN, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008  0.454
2017 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W  0.39
2017 Gardener SL, Rainey-Smith SR, Sohrabi HR, Weinborn M, Verdile G, Fernando WM, Lim YY, Harrington K, Burnham S, Taddei K, Masters CL, Macaulay SL, Rowe CC, Ames D, Maruff P, ... Martins RN, et al. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner. Journal of Alzheimer's Disease : Jad. PMID 28387666 DOI: 10.3233/Jad-161158  0.68
2017 Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, Dave P, Ball B, ManYan C, Taddei K, Chung R, Garg ML, Martins RN. Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease. Scientific Reports. 7: 676. PMID 28386119 DOI: 10.1038/s41598-017-00751-2  0.308
2017 Frost S, Bhuiyan A, Offerman D, Doecke JD, Macaulay SL, Sohrabi HR, Ames D, Masters C, Martins RN, Kanagasingam Y, Aibl Research Group. Modulation of Retinal Arteriolar Central Reflection by APOE genotype. Current Alzheimer Research. PMID 28290247 DOI: 10.2174/1567205014666170309115016  0.42
2017 Golzan SM, Goozee K, Georgevsky D, Avolio A, Chatterjee P, Shen K, Gupta V, Chung R, Savage G, Orr CF, Martins RN, Graham SL. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease. Alzheimer's Research & Therapy. 9: 13. PMID 28253913 DOI: 10.1186/s13195-017-0239-9  0.314
2017 Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, et al. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28234254 DOI: 10.3233/Jad-161019  0.497
2017 Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/Jad-160622  0.584
2017 Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study. Journal of Alzheimer's Disease : Jad. PMID 28106562 DOI: 10.3233/Jad-161050  0.389
2017 Shah TM, Gupta SM, Chatterjee P, Campbell M, Martins RN. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Molecular Psychiatry. PMID 28093567 DOI: 10.1038/Mp.2016.251  0.454
2017 Shah TM, Weinborn M, Verdile G, Sohrabi HR, Martins RN. Enhancing Cognitive Functioning in Healthly Older Adults: a Systematic Review of the Clinical Significance of Commercially Available Computerized Cognitive Training in Preventing Cognitive Decline. Neuropsychology Review. PMID 28092015 DOI: 10.1007/S11065-016-9338-9  0.535
2017 Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043  0.425
2017 Ashton NJ, Narvardo-Holgado AJ, Lynham S, Ward M, Gupta VB, Chatterjee P, Goozee K, Hone E, Pedrini S, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Aarsland D, ... ... Martins R, et al. A mass spectrometry-based discovery and replication of a multi-analyte classifier for neocortical amyloid pathology Alzheimers & Dementia. 13: 1033. DOI: 10.1016/J.Jalz.2017.06.1456  0.553
2016 O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, ... ... Martins R, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27870940 DOI: 10.1016/J.Jalz.2016.09.014  0.382
2016 Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Martins RN, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0  0.402
2016 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, et al. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27742526 DOI: 10.1016/J.Jagp.2016.08.007  0.369
2016 Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Corrigendum: Corrigendum to 'Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment'. Age and Ageing. 45: 742. PMID 27646269 DOI: 10.1093/Ageing/Afw117  0.361
2016 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Journal of Molecular Neuroscience : Mn. PMID 27586003 DOI: 10.1007/s12031-016-0822-8  0.493
2016 Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA. Associations of neighborhood environment with brain imaging outcomes in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27546307 DOI: 10.1016/j.jalz.2016.06.2364  0.355
2016 Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, et al. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up. Neurology. PMID 27534714 DOI: 10.1212/Wnl.0000000000003094  0.589
2016 Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet. Neurology. PMID 27450471 DOI: 10.1016/S1474-4422(16)30125-9  0.496
2016 Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078  0.415
2016 Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT. Alzheimer`s disease and the early signs of age-related macular degeneration. Current Alzheimer Research. PMID 27335042 DOI: 10.2174/1567205013666160603003800  0.481
2016 Gupta V, Gupta VB, Chitranshi N, Gangoda S, Vander Wall R, Abbasi M, Golzan M, Dheer Y, Shah T, Avolio A, Chung R, Martins R, Graham S. One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. Cellular and Molecular Life Sciences : Cmls. PMID 27333888 DOI: 10.1007/S00018-016-2295-X  0.427
2016 Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN, et al. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 18-26. PMID 27239546 DOI: 10.1016/J.Dadm.2015.12.001  0.609
2016 Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 19-26. PMID 27239532 DOI: 10.1016/j.dadm.2015.11.003  0.471
2016 Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry. PMID 27114112 DOI: 10.1002/gps.4489  0.428
2016 Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN, et al. The Relationship between Sleep Quality and Brain Amyloid Burden. Sleep. PMID 27091528  0.35
2016 Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A. sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. PMID 27063405 DOI: 10.1016/J.Biocel.2016.04.002  0.414
2016 Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, Shah T, Foster JK, Lenzo N, Salvado O, Laske C, Laws SM, Taddei K, Verdile G, Martins RN. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults. Journal of Alzheimer's Disease : Jad. PMID 27031482 DOI: 10.3233/Jad-151084  0.549
2016 Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease. Neurology. PMID 27029632 DOI: 10.1212/Wnl.0000000000002604  0.482
2016 O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, King M, et al. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 27-34. PMID 27019866 DOI: 10.1016/J.Dadm.2015.12.003  0.318
2016 Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... Martins RN, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647  0.462
2016 François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease. Current Alzheimer Research. PMID 26975368 DOI: 10.2174/1567205013666160315112151  0.484
2016 Hare DJ, Faux NG, Roberts BR, Volitakis I, Martins RN, Bush AI. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Metallomics : Integrated Biometal Science. PMID 26962965 DOI: 10.1039/C6Mt00019C  0.546
2016 Bird SM, Sohrabi HR, Sutton TA, Weinborn M, Rainey-Smith SR, Brown B, Patterson L, Taddei K, Gupta V, Carruthers M, Lenzo N, Knuckey N, Bucks RS, Verdile G, Martins RN. Cerebral amyloid-β accumulation and deposition following traumatic brain injury-A narrative review and meta-analysis of animal studies. Neuroscience and Biobehavioral Reviews. PMID 26899257 DOI: 10.1016/J.Neubiorev.2016.01.004  0.613
2016 Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26852195 DOI: 10.1016/j.jalz.2015.12.013  0.421
2016 Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, ... ... Martins RN, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948  0.424
2016 Porter T, Bharadwaj P, Groth D, Paxman A, Laws SM, Martins RN, Verdile G. The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity. Journal of Alzheimer's Disease : Jad. PMID 26836170 DOI: 10.3233/Jad-150790  0.612
2016 Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN. The relationship between sleep quality and brain amyloid burden Sleep. 39: 1063-1068. DOI: 10.5665/sleep.5756  0.342
2016 Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 18-26. DOI: 10.1016/j.dadm.2015.12.001  0.568
2015 Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, et al. Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease. Bjpsych Open. 1: 139-148. PMID 27703739 DOI: 10.1192/bjpo.bp.115.001339  0.379
2015 Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators of Inflammation. 2015: 105828. PMID 26693205 DOI: 10.1155/2015/105828  0.607
2015 Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. The British Journal of Nutrition. 1-17. PMID 26652155 DOI: 10.1017/S0007114515004687  0.697
2015 Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446  0.556
2015 Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, ... ... Martins RN, et al. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Alzheimer's Research & Therapy. 7: 71. PMID 26581886 DOI: 10.1186/s13195-015-0157-7  0.41
2015 Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, Foster J, Carruthers M, Verdile G, Sohrabi HR, Martins RN. The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men. Cns & Neurological Disorders Drug Targets. PMID 26553159 DOI: 10.2174/1871527315666151110125704  0.573
2015 Barr RK, Verdile G, Wijaya LK, Morici M, Taddei K, Gupta VB, Pedrini S, Jin L, Nicolazzo JA, Knock E, Fraser PE, Martins RN. Validation and Characterisation of a Novel Peptide that Binds Monomeric and Aggregated Beta-amyloid and Inhibits the Formation of Neurotoxic Oligomers. The Journal of Biological Chemistry. PMID 26538562 DOI: 10.1074/Jbc.M115.679993  0.613
2015 Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44: 1012-9. PMID 26452663 DOI: 10.1093/Ageing/Afv136  0.354
2015 Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months. Plos One. 10: e0139082. PMID 26430784 DOI: 10.1371/journal.pone.0139082  0.432
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease : Jad. 46: 1079-89. PMID 26402634 DOI: 10.3233/JAD-143015  0.429
2015 Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. 48: 443-52. PMID 26402008 DOI: 10.3233/Jad-150330  0.553
2015 Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, ... ... Martins RN, et al. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Alzheimer's Disease : Jad. 48: 175-87. PMID 26401938 DOI: 10.3233/JAD-150247  0.47
2015 Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Martins RN, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903  0.449
2015 Verdile G, Asih PR, Barron AM, Wahjoepramono EJ, Ittner LM, Martins RN. The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies. Hormones and Behavior. PMID 26122291 DOI: 10.1016/J.Yhbeh.2015.05.020  0.535
2015 Xu H, Gupta VB, Martins IJ, Martins RN, Fowler CJ, Bush AI, Finkelstein DI, Adlard PA. Zinc affects the proteolytic stability of Apolipoprotein E in an isoform-dependent way. Neurobiology of Disease. PMID 26117305 DOI: 10.1016/J.Nbd.2015.06.016  0.5
2015 Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status. Neuropsychologia. 75: 411-419. PMID 26102189 DOI: 10.1016/J.Neuropsychologia.2015.06.008  0.449
2015 Verdile G, Fuller SJ, Martins RN. The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease. PMID 25926349 DOI: 10.1016/J.Nbd.2015.04.008  0.535
2015 Laske C, Sohrabi HR, Jasielec MS, Müller S, Koehler NK, Gräber S, Förster S, Drzezga A, Mueller-Sarnowski F, Danek A, Jucker M, Bateman RJ, Buckles V, Saykin AJ, Martins RN, et al. Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study. Biomed Research International. 2015: 828120. PMID 25922840 DOI: 10.1155/2015/828120  0.372
2015 Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, de Ruyck K, Taddei K, Fuller SJ, Sohrabi H, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. Cns & Neurological Disorders Drug Targets. 14: 576-86. PMID 25921747 DOI: 10.2174/1871527314666150429112112  0.535
2015 Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, ... Martins RN, et al. Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer's Research & Therapy. 7: 16. PMID 25859282 DOI: 10.1186/S13195-015-0105-6  0.604
2015 Moussavi Nik SH, Newman M, Wilson L, Ebrahimie E, Wells S, Musgrave I, Verdile G, Martins RN, Lardelli M. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity. Human Molecular Genetics. 24: 3662-78. PMID 25814654 DOI: 10.1093/Hmg/Ddv110  0.634
2015 Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology. 29: 571-81. PMID 25664464 DOI: 10.1037/Neu0000156  0.469
2015 Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. Jama Psychiatry. 72: 284-91. PMID 25629787 DOI: 10.1001/jamapsychiatry.2014.2476  0.486
2015 Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 917-25. PMID 25613103 DOI: 10.3233/Jad-141497  0.515
2015 Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiology of Aging. 36: 1231-8. PMID 25585532 DOI: 10.1016/j.neurobiolaging.2014.12.015  0.378
2015 Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiology of Aging. 36: 1239-44. PMID 25559335 DOI: 10.1016/j.neurobiolaging.2014.12.008  0.484
2015 Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 30: 49-58. PMID 25467942 DOI: 10.1093/arclin/acu068  0.491
2015 O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, ... ... Martins R, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 549-60. PMID 25282381 DOI: 10.1016/J.Jalz.2014.08.099  0.378
2015 Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J. Comparison of MR-less PiB SUVR quantification methods. Neurobiology of Aging. 36: S159-66. PMID 25257985 DOI: 10.1016/J.Neurobiolaging.2014.04.033  0.389
2015 Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease : Jad. 43: 677-86. PMID 25114076 DOI: 10.3233/JAD-140678  0.468
2015 Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, ... ... Martins RN, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20: 860-6. PMID 25070537 DOI: 10.1038/Mp.2014.79  0.38
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study Journal of Alzheimer's Disease. 46: 1079-1089. DOI: 10.3233/JAD-143015  0.39
2014 Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P. Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. Bmc Bioinformatics. 15: S11. PMID 25521394 DOI: 10.1186/1471-2105-15-S16-S11  0.418
2014 Shah T, Verdile G, Sohrabi H, Campbell A, Putland E, Cheetham C, Dhaliwal S, Weinborn M, Maruff P, Darby D, Martins RN. A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly. Translational Psychiatry. 4: e487. PMID 25463973 DOI: 10.1038/Tp.2014.122  0.58
2014 Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians. Neurodegenerative Disease Management. 4: 363-78. PMID 25405650 DOI: 10.2217/Nmt.14.29  0.659
2014 Moussavi Nik SH, Newman M, Ganesan S, Chen M, Martins R, Verdile G, Lardelli M. Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts. Bmc Research Notes. 7: 767. PMID 25359609 DOI: 10.1186/1756-0500-7-767  0.615
2014 Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Molecular Psychiatry. PMID 25349172 DOI: 10.1038/mp.2014.127  0.411
2014 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Molecular Psychiatry. PMID 25288138 DOI: 10.1038/mp.2014.123  0.498
2014 Martins R, Carruthers M. Testosterone as the missing link between pesticides, Alzheimer disease, and Parkinson disease. Jama Neurology. 71: 1189-90. PMID 25200541 DOI: 10.1001/Jamaneurol.2014.795  0.374
2014 Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, ... ... Martins RN, et al. Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology. 83: 1345-52. PMID 25186863 DOI: 10.1212/Wnl.0000000000000867  0.459
2014 Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Martins RN, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654  0.426
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, et al. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults. International Psychogeriatrics / Ipa. 26: 1737-46. PMID 24969443 DOI: 10.1017/S1041610214001136  0.483
2014 François M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells. Current Alzheimer Research. 11: 519-31. PMID 24938500 DOI: 10.2174/1567205011666140618103827  0.447
2014 Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596  0.435
2014 Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273: 65-71. PMID 24907904 DOI: 10.1016/J.Jneuroim.2014.05.005  0.609
2014 Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/C4Mt00060A  0.646
2014 Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82: 1266-73. PMID 24623839 DOI: 10.1212/Wnl.0000000000000285  0.477
2014 François M, Leifert W, Hecker J, Faunt J, Martins R, Thomas P, Fenech M. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 85: 698-708. PMID 24616437 DOI: 10.1002/Cyto.A.22453  0.421
2014 Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901  0.498
2014 Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 743-751.e1. PMID 24589436 DOI: 10.1016/j.jalz.2013.11.005  0.497
2014 Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 204: 400-1. PMID 24526746 DOI: 10.1192/Bjp.Bp.113.134239  0.389
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. Journal of Alzheimer's Disease : Jad. 40: 551-61. PMID 24496075 DOI: 10.3233/Jad-131820  0.363
2014 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. Plos One. 9: e86498. PMID 24475133 DOI: 10.1371/Journal.Pone.0086498  0.585
2014 Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer's disease. Molecular Psychiatry. 19: 1227-34. PMID 24419041 DOI: 10.1038/Mp.2013.178  0.615
2014 Bates K, Vink R, Martins R, Harvey A. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain. Neurobiology of Aging. 35: 1345-51. PMID 24360504 DOI: 10.1016/J.Neurobiolaging.2013.11.020  0.442
2014 Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Journal of Alzheimer's Disease : Jad. 40: 95-104. PMID 24334723 DOI: 10.3233/Jad-131802  0.595
2014 Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, et al. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics / Ipa. 26: 543-54. PMID 24252258 DOI: 10.1017/S1041610213001956  0.601
2014 Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. Journal of Alzheimer's Disease : Jad. 39: 661-8. PMID 24246419 DOI: 10.3233/Jad-131265  0.531
2014 Kanyenda LJ, Verdile G, Martins R, Meloni BP, Chieng J, Mastaglia F, Laws SM, Anderton RS, Boulos S. Is cholesterol and amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated neuroprotection is reliant on CD147. Journal of Alzheimer's Disease : Jad. 39: 545-56. PMID 24217276 DOI: 10.3233/Jad-131442  0.592
2014 Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain : a Journal of Neurology. 137: 221-31. PMID 24176981 DOI: 10.1093/brain/awt286  0.479
2014 Newman M, Wilson L, Verdile G, Lim A, Khan I, Moussavi Nik SH, Pursglove S, Chapman G, Martins RN, Lardelli M. Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease. Human Molecular Genetics. 23: 602-17. PMID 24101600 DOI: 10.1093/Hmg/Ddt448  0.626
2014 Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry. 19: 519-26. PMID 23628985 DOI: 10.1038/Mp.2013.40  0.567
2014 Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, ... ... Martins RN, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/J.Jalz.2012.12.006  0.599
2014 Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, ... Martins RN, et al. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. 19: 69-75. PMID 23089633 DOI: 10.1038/Mp.2012.147  0.745
2014 Sharman M, Ong D, Verdile G, Munch G, Wenk M, Halliwell B, Martins R. Effect of nutritional supplement therapies in the prevention of Alzheimer’s disease in a transgenic mouse model Journal of Nutrition & Intermediary Metabolism. 1: 32. DOI: 10.1016/J.Jnim.2014.10.113  0.535
2014 Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Comparison Of Three Normative Data Correction Approaches: A Cross-Sectional Evaluation In The Aibl Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.064  0.357
2014 Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Novel Statistically-Derived Composite Measures For Assessing The Efficacy Of Disease-Modifying Therapies In Prodromal Ad Trials: An Aipl Study Alzheimers & Dementia. 10: 567. DOI: 10.1016/J.Jalz.2014.05.927  0.465
2014 Francois M, Fenech MF, Leifert W, Hecker J, Faunt J, Martins R, Thomas P. Nuclear Shape, Dna Ploidy, And Lipid Content As Measured By High Content Analysis Laser Scanning Cytometry Is Significantly Altered In Buccal Cells From Individuals With Mild Cognitive Impairment Or Alzheimer'S Disease Alzheimers & Dementia. 10: 520. DOI: 10.1016/J.Jalz.2014.05.809  0.347
2014 Buckley R, Saling M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay L, Martins R, Szoeke C, Masters C, Rainey-Smith SR, Rembach A, Savage G, Ellis KA. P4-164: QUALITATIVE THEMATIC ANALYSIS OF SUBJECTIVE MEMORY COMPLAINTS IN THE HEALTHY ELDERLY AND INDIVIDUALS WITH MCI Alzheimer's & Dementia. 10: P849-P850. DOI: 10.1016/J.Jalz.2014.05.1681  0.417
2014 Gupta VB, Pedrini S, Hone E, Deocke J, Obryant S, Masters CL, Martins R. Peripheral Biomarkers Differentiate Between Transitional And Non-Transitional Clinical Groups In The Longitudinal Australian Imaging Biomarkers And Lifestyle Study Of Aging Alzheimers & Dementia. 10: 807. DOI: 10.1016/J.Jalz.2014.05.1582  0.407
2014 Asih PR, Wahjoepramono EJ, Aniwiyanti V, Taddei K, Fuller S, Sohrabi HR, Dhaliwal S, Verdile G, Carruthers M, Martins RN. P3-389: PHYSIOLOGICAL EFFECTS AND SAFETY ASSESSMENT OF TESTOSTERONE REPLACEMENT THERAPY IN OLDER MALE SUBJECTIVE MEMORY COMPLAINERS Alzheimer's & Dementia. 10: P772-P772. DOI: 10.1016/J.Jalz.2014.05.1483  0.535
2014 Fowler CJ, Yevenes LF, Rembach A, Faux NG, Trounson B, Pertile K, Rumble R, Ellis KA, Ames D, Bush AI, Martins R, Masters CL. P3-114: ELEVATED BLOOD HDL AND HDL-ASSOCIATED LIPOPROTEINS IN HEALTHY CONTROLS WHO RAPIDLY CONVERT TO ALZHEIMER'S DISEASE IN THE AIBL COHORT Alzheimer's & Dementia. 10: P670-P670. DOI: 10.1016/J.Jalz.2014.05.1203  0.591
2014 Yates P, Villemagne VL, Bourgeat P, Ellis KA, Martins R, Szoeke C, Desmond P, Masters CL, Ames D, Rowe CC. Brain Beta-Amyloid, Vascular Factors, And Cognition: 54-Month Followup Results From The Aipl Study Alzheimers & Dementia. 10: 17. DOI: 10.1016/J.Jalz.2014.05.026  0.475
2014 Bourgeat P, Doré V, Zhou L, Fripp J, Martins R, Macaulay L, Masters CL, Ames D, Brown B, Rowe CC, Salvado O, Villemagne VL. Automated Reporting Of Amyloid Pet Quantification On Brain Surface Through A Web Interface Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.424  0.418
2014 Chatterjee P, Lim WLF, Gupta VB, Sohrabi HR, Taddei K, Brown B, Masters CL, Morris JC, Martins R. Altered Plasma Phospholipid Composition In Autosomal Dominant Alzheimer'S Disease: A Dian Study Alzheimers & Dementia. 10: 260. DOI: 10.1016/J.Jalz.2014.04.412  0.494
2014 Frost S, Kanagasingam Y, Macaulay L, Koronyo-Hamaoui M, Koronyo Y, Biggs D, Verdooner S, Black K, Taddei K, Shah T, Rainey-Smith S, Bourgeat P, Salvado O, Doecke J, Wilson B, ... ... Martins R, et al. Retinal Amyloid Fluorescence Imaging Predicts Cerebral Amyloid Burden And Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.341  0.403
2014 Villemagne VL, Burnham S, Brown B, Bourgeat P, Ellis KA, Yates P, Veljanovski R, Martins R, Macaulay L, Salvado O, Ames D, Masters CL, Rowe CC. PRECLINICAL EFFECTS OF Aβ DEPOSITION ON EPISODIC MEMORY AND DISEASE PROGRESSION Alzheimers & Dementia. 10: 229. DOI: 10.1016/J.Jalz.2014.04.326  0.477
2014 Burnham SC, Ames D, Baker D, Bush AI, Cobiac L, Doecke J, Ellis KA, Faux NG, Head R, Kiiveri H, Laws SM, Martins R, Maruff P, Savage G, Wilson B, et al. Predicting Alzheimer'S Disease From A Blood-Based Biomarker Profile: Results From Aipl At 54 Months Alzheimers & Dementia. 10: 196. DOI: 10.1016/J.Jalz.2014.04.233  0.461
2014 Rainey-Smith SR, Brown B, Gardener S, Peiffer J, Bourgeat P, Laws SM, Barnes M, Taddei K, Sohrabi HR, Weinborn M, Rembach A, Burnham S, Villemagne VL, Ellis KA, Macaulay L, ... ... Martins R, et al. Apoe Genotype-Dependent Effects Of Diet And Physical Activity On Cognition And Alzheimer'S-Related Pathology: Data From The Aipl Study Of Ageing Alzheimers & Dementia. 10: 166. DOI: 10.1016/J.Jalz.2014.04.165  0.516
2014 Harrington K, Gould E, Lim YY, Ellis KA, Ames D, Martins R, Savage G, Szoeke C, Rowe CC, Villemagne VL, Masters CL, Maruff P. The Association Between Amyloid Burden And Sub-Clinical Depression In Healthy Older Adults Alzheimers & Dementia. 10: 139. DOI: 10.1016/J.Jalz.2014.04.086  0.421
2013 Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, ... ... Martins R, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Annals of Neurology. 74: 905-13. PMID 24448836 DOI: 10.1002/Ana.24040  0.495
2013 Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Translational Psychiatry. 3: e332. PMID 24301650 DOI: 10.1038/Tp.2013.97  0.672
2013 Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Martins R, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110  0.49
2013 Gupta VB, Gupta VK, Martins R. Semagacestat for treatment of Alzheimer's disease. The New England Journal of Medicine. 369: 1660-1. PMID 24152268 DOI: 10.1056/Nejmc1310845  0.393
2013 Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. Current Alzheimer Research. 10: 931-9. PMID 24117119 DOI: 10.2174/15672050113106660163  0.478
2013 Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, ... ... Martins RN, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Revue Neurologique. 169: 737-43. PMID 24016464 DOI: 10.1016/J.Neurol.2013.07.017  0.355
2013 Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe C, Watters DA, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 36: 2981-7. PMID 24009301 DOI: 10.2337/Dc13-0229  0.44
2013 Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154  0.427
2013 Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. International Psychogeriatrics / Ipa. 25: 1667-77. PMID 23866942 DOI: 10.1017/S1041610213001087  0.501
2013 Sharman MJ, Moussavi Nik SH, Chen MM, Ong D, Wijaya L, Laws SM, Taddei K, Newman M, Lardelli M, Martins RN, Verdile G. The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes. Plos One. 8: e66235. PMID 23805206 DOI: 10.1371/Journal.Pone.0066235  0.614
2013 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2457-64. PMID 23769397 DOI: 10.1016/J.Neurobiolaging.2013.05.006  0.612
2013 Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain : a Journal of Neurology. 136: 2201-16. PMID 23737466 DOI: 10.1093/Brain/Awt127  0.468
2013 Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Jama Neurology. 70: 903-11. PMID 23712469 DOI: 10.1001/Jamaneurol.2013.1062  0.523
2013 Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics / Ipa. 25: 1307-15. PMID 23693133 DOI: 10.1017/S1041610213000665  0.479
2013 Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. Neuropsychology. 27: 322-32. PMID 23688214 DOI: 10.1037/A0032321  0.598
2013 Lim WL, Lam SM, Shui G, Mondal A, Ong D, Duan X, Creegan R, Martins IJ, Sharman MJ, Taddei K, Verdile G, Wenk MR, Martins RN. Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E ε3 and ε4 knock-in mice. Neurobiology of Aging. 34: 2217-24. PMID 23601809 DOI: 10.1016/J.Neurobiolaging.2013.03.012  0.535
2013 Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, et al. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 320-30. PMID 23552802 DOI: 10.1093/Arclin/Act021  0.585
2013 Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet. Neurology. 12: 357-67. PMID 23477989 DOI: 10.1016/S1474-4422(13)70044-9  0.474
2013 Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Translational Psychiatry. 3: e233. PMID 23443359 DOI: 10.1038/Tp.2012.150  0.472
2013 O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R. Biomarkers of Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease : Jad. 34: 841-9. PMID 23313927 DOI: 10.3233/Jad-122074  0.42
2013 Ellis KA, Lim YY, Harrington K, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 34: 861-71. PMID 23302660 DOI: 10.3233/Jad-122170  0.546
2013 Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ. Research and standardization in Alzheimer's trials: reaching international consensus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 160-8. PMID 23266004 DOI: 10.1016/J.Jalz.2012.10.006  0.477
2013 Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/Jad-121474  0.601
2013 Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 33: 1167-76. PMID 23160011 DOI: 10.3233/Jad-121771  0.528
2013 Lim YY, Ellis KA, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 538-45. PMID 23159043 DOI: 10.1016/J.Jalz.2012.07.004  0.451
2013 Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P. Rapid decline in episodic memory in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 33: 675-9. PMID 23001710 DOI: 10.3233/Jad-2012-121516  0.506
2013 Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, ... ... Martins RN, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry. 18: 875-81. PMID 22889922 DOI: 10.1038/Mp.2012.107  0.612
2013 Steele JW, Ju S, Lachenmayer ML, Liken J, Stock A, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, ... ... Martins RN, et al. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain. Molecular Psychiatry. 18: 882-8. PMID 22869031 DOI: 10.1038/Mp.2012.115  0.629
2013 Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, ... ... Martins RN, et al. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Molecular Psychiatry. 18: 889-97. PMID 22850627 DOI: 10.1038/Mp.2012.106  0.665
2013 Copolov C, Harrington K, Dow B, Joosten M, Rainey-Smith S, Rodrigues M, Rembach A, Macaulay L, Rowe C, Martins R, Masters C, Ames D, Ellis K. The effect of rapid cognitive decline in MCI and Alzheimer's disease on level of dependence, resource utilization, carer satisfaction, burden and attitudes to aging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.996  0.537
2013 Buckley R, Saling M, Irish M, Ames D, Rowe C, Lautenschlager N, Maruff P, Macaulay L, Martins R, Masters C, O'Meara T, Savage G, Szoeke C, Villemagne V, Ellis K. P2-267: Neuropsychological predictors of autobiographical memory impairment in mild cognitive impairment (MCI) Alzheimer's & Dementia. 9: P456-P456. DOI: 10.1016/J.Jalz.2013.05.914  0.465
2013 Johnson P, Graham P, Wilson B, Macaulay L, Maruff P, Savage G, Ellis K, Martins R, Rowe C, Masters C, Ames D, Zhang P. Genetic algorithm with logistic regression for Alzheimer's disease diagnosis and prognosis Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.913  0.461
2013 Restrepo C, Saling M, Ames D, Bush A, Faux N, Martins R, Maruff P, Masters C, Rowe C, Szoeke C, Villemagne V, Yates P, Ellis K. The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.911  0.566
2013 Lim YY, Villemagne V, Laws S, Ames D, Pietrzak R, Ellis K, Harrington K, Bourgeat P, Salvado O, Darby D, Snyder P, Bush A, Martins R, Masters C, Rowe C, et al. Modulation of beta-amyloid-related cognitive decline by brain-derived neurotrophic factor Val66Met polymorphism in preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.893  0.634
2013 Lim YY, Ellis K, Harrington K, Kamer A, Pietrzak R, Bush A, Darby D, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Ames D, Maruff P. Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease Alzheimers & Dementia. 9: 446. DOI: 10.1016/J.Jalz.2013.05.891  0.632
2013 Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. Cortical surface projection of PET images from 11C- and 18F-labeled radiotracers without magnetic resonance imaging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.523  0.368
2013 Zhang P, Graham P, Savage G, Jones A, Macaulay L, Masters C, Martins R, Gupta VB, Bush A, Maruff P, Ellis K, Szoeke C, Rowe C, Ames D, Wilson B. Change in cognition over 36 months in relation to blood biomarkers Alzheimers & Dementia. 9: 204. DOI: 10.1016/J.Jalz.2013.05.372  0.565
2013 Rembach A, Wilson B, Ellis K, Ames D, Rowe C, Villemagne V, Bush A, Martins R, Masters C, Doecke J. Neutrophil-lymphocyte ratio in Alzheimer's disease: Data from the Australian Imaging Biomarker and Lifestyle study of ageing Alzheimers & Dementia. 9: 203. DOI: 10.1016/J.Jalz.2013.05.368  0.611
2013 Thomas J, Brier M, Bateman R, Snyder A, Benzinger T, Xiong C, Raichle M, Sperling R, Mayeux R, Ghetti B, Ringman J, Salloway S, McDade E, Rossor M, Schofield P, ... ... Martins R, et al. IC-P-184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 9: P105-P105. DOI: 10.1016/J.Jalz.2013.05.181  0.461
2013 Zhang P, Macaulay L, Martins R, Maruff P, Savage G, Ellis K, Szoeke C, Masters C, Rowe C, Ames D, Riley M. P4-217: Association of BMI and change in BMI with cognitive function, change in cognitive function and conversion to Alzheimer's disease Alzheimer's & Dementia. 9: P785-P786. DOI: 10.1016/J.Jalz.2013.05.1609  0.499
2013 Maruff P, Lim YY, Ames D, Ellis K, Pietrzak R, Savage G, Harrington K, Bush A, Szoeke C, Martins R, Villemagne V, Rowe C, Darby D, Masters C. Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1296  0.588
2013 Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Martins R, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075  0.478
2013 Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.017  0.366
2013 Rowe C, Ames D, Ellis K, Bourgeat P, Brown B, Salvado O, Szoeke C, Woodward M, Macaulay L, Maruff P, Martins R, Masters C, Villemagne V. Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Alzheimers & Dementia. 9: 12. DOI: 10.1016/J.Jalz.2013.05.005  0.472
2013 Bourgeat P, Villemagne V, Dore V, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Rowe C, Salvado O. Automatic 11C PiB SUVR quantification Alzheimers & Dementia. 9: 597. DOI: 10.1016/J.Jalz.2013.05.004  0.353
2013 Rembach A, Wilson B, Villemagne V, Ellis K, Ames D, Rowe C, Bush A, Martins R, Masters C, Doecke J. Plasma beta-amyloid levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.341  0.647
2013 Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O, Szoeke C, Macaulay L, Martins R, Maruff P, Ames D, Rowe C, Masters C. The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.253  0.541
2013 Yates P, Villemagne V, Desmond P, Phal P, Steward C, Salvado O, Martins R, Masters C, Ames D, Ellis K, Szoeke C, Rowe C. Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Alzheimers & Dementia. 9: 131. DOI: 10.1016/J.Jalz.2013.04.066  0.416
2013 Gupta VB, Rowe C, Szoeke C, Ames D, Cobiac L, Bush A, Ellis K, Macaulay L, Masters C, Martins R. Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging Alzheimers & Dementia. 9: 128. DOI: 10.1016/J.Jalz.2013.04.057  0.618
2013 Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Martins R, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017  0.466
2012 Avdesh A, Chen M, Martin-Iverson MT, Mondal A, Ong D, Rainey-Smith S, Taddei K, Lardelli M, Groth DM, Verdile G, Martins RN. Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction. Journal of Visualized Experiments : Jove. e4196. PMID 23183629 DOI: 10.3791/4196  0.535
2012 Brown BM, Peiffer JJ, Sohrabi HR, Mondal A, Gupta VB, Rainey-Smith SR, Taddei K, Burnham S, Ellis KA, Szoeke C, Masters CL, Ames D, Rowe CC, Martins RN. Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry. 2: e191. PMID 23168991 DOI: 10.1038/Tp.2012.118  0.341
2012 Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93  0.463
2012 Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology. 79: 1645-52. PMID 23071163 DOI: 10.1212/Wnl.0B013E31826E9Ae6  0.406
2012 Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. Bmc Psychiatry. 12: 167. PMID 23050829 DOI: 10.1186/1471-244X-12-167  0.43
2012 Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, ... ... Martins RN, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry. 2: e164. PMID 23032941 DOI: 10.1038/Tp.2012.91  0.47
2012 Bharadwaj PR, Verdile G, Barr RK, Gupta V, Steele JW, Lachenmayer ML, Yue Z, Ehrlich ME, Petsko G, Ju S, Ringe D, Sankovich SE, Caine JM, Macreadie IG, Gandy S, ... Martins RN, et al. Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast. Journal of Alzheimer's Disease : Jad. 32: 949-67. PMID 22903131 DOI: 10.3233/Jad-2012-120178  0.592
2012 Sohrabi HR, Bates KA, Weinborn MG, Johnston AN, Bahramian A, Taddei K, Laws SM, Rodrigues M, Morici M, Howard M, Martins G, Mackay-Sim A, Gandy SE, Martins RN. Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Translational Psychiatry. 2: e118. PMID 22832962 DOI: 10.1038/Tp.2012.43  0.348
2012 Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, ... ... Martins RN, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology. 69: 1318-25. PMID 22801742 DOI: 10.1001/Archneurol.2012.1282  0.597
2012 Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Martins RN, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753  0.462
2012 Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain : a Journal of Neurology. 135: 2126-39. PMID 22628162 DOI: 10.1093/Brain/Aws125  0.423
2012 Barber B, Ames D, Ellis K, Martins R, Masters C, Szoeke C. Lifestyle and late life cognitive health: sufficient evidence to act now? International Psychogeriatrics / Ipa. 24: 683-8. PMID 22313892 DOI: 10.1017/S1041610211002912  0.422
2012 Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology. 78: 477-84. PMID 22302548 DOI: 10.1212/Wnl.0B013E318246D67A  0.501
2012 Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Clinical and Experimental Neuropsychology. 34: 345-58. PMID 22248010 DOI: 10.1080/13803395.2011.643227  0.468
2012 Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, Chételat G, Rueda A, Villemagne VL, Szoeke C, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Bonner E, et al. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods. 205: 96-109. PMID 22226742 DOI: 10.1016/J.Jneumeth.2011.12.011  0.425
2012 Avdesh A, Martin-Iverson MT, Mondal A, Chen M, Askraba S, Morgan N, Lardelli M, Groth DM, Verdile G, Martins RN. Evaluation of color preference in zebrafish for learning and memory. Journal of Alzheimer's Disease : Jad. 28: 459-69. PMID 22008261 DOI: 10.3233/Jad-2011-110704  0.535
2012 Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics / Ipa. 24: 197-204. PMID 21749739 DOI: 10.1017/S1041610211001335  0.601
2012 Doré V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis KA, Martins RN, Villemagne V, Masters CL, Ames D, Rowe CC, Salvado O. A surface based approach for cortical thickness comparison between PiB+ and PiB-healthy control subjects Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911752  0.446
2012 Laws SM, Verdile G, Doecke J, Martins RN. Diagnostic and therapeutic approaches to alzheimer’s disease Pathology. 44: S17. DOI: 10.1016/S0031-3025(16)32639-3  0.535
2012 Villemagne V, Ellis K, Bourgeat P, Brown B, Jones G, Fripp J, Martins R, Salvado O, Ames D, Masters C, Rowe C. Sigmoidal kinetics of BETA-AMYLOID deposition: Twenty-year interval between normality and fully developed Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.148  0.511
2012 Appannah A, Szoeke C, Ellis K, Rowe C, Martins R, Masters C, Ames D, Bush A. Investigating cardiovascular risk factors on cognition: A two-cohort study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.878  0.557
2012 Faux N, Burnham S, Wilson B, Jones G, Laws S, Bedo J, Ames D, Bush A, Doecke J, Ellis K, Head R, Kiiveri H, Macaulay L, Martins R, Masters C, et al. An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden Alzheimers & Dementia. 8: 283. DOI: 10.1016/J.Jalz.2012.05.764  0.569
2012 Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, ... ... Martins R, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655  0.491
2012 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, ... ... Martins R, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654  0.48
2012 Shah T, Verdile G, Sohrabi H, Martins R. P1-129: Physical activity and cognitive stimulation improve cognition and alter levels of plasma beta-amyloid in healthy elderly Alzheimer's & Dementia. 8: P151-P151. DOI: 10.1016/J.Jalz.2012.05.406  0.579
2012 Burnham S, Graham P, Wilson B, Ames D, Macaulay L, Martins R, Masters C, Maruff P, Rowe C, Szoeke C, Ryan L, Ellis K. Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort Alzheimers & Dementia. 8: 131. DOI: 10.1016/J.Jalz.2012.05.347  0.521
2012 Burnham S, Wilson B, Graham P, Kiiveri H, Ames D, Macaulay L, Martins R, Masters C, Rowe C, Salvado O, Szoeke C, Villemagne V, Ellis K. Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.346  0.474
2012 Villemagne V, Ellis K, Chetelat G, Brown B, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Relation between rates of Aβ deposition, APOE genotype and cognition: Results from a 3- to 5-year longitudinal study Alzheimers & Dementia. 8: 113. DOI: 10.1016/J.Jalz.2012.05.293  0.505
2012 Gupta VB, Wilson A, Rainey-Smith S, Laws S, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.285  0.616
2012 Shah T, Verdile G, Sohrabi H, Martins R. O1-08-03: Cross-training of auditory and visual brain training software program improves cognition and alters plasma BDNF levels in healthy older adults Alzheimer's & Dementia. 8: P99-P99. DOI: 10.1016/J.Jalz.2012.05.247  0.579
2012 Rainey-Smith S, Brown B, Ruyck KD, Laws S, Wilson A, Gupta VB, Ames D, Ellis K, Taddei K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Martins R. Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2035  0.484
2012 Laws S, Bender S, Rainey-Smith S, Wilson A, Gupta VB, Ruyck Kd, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study Alzheimers & Dementia. 8: 407. DOI: 10.1016/J.Jalz.2012.05.2034  0.595
2012 Benzinger T, Blazey T, Ances B, Raichle M, Ances B, Snyder A, Su Y, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Martins R, et al. IC-P-128: Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study Alzheimer's & Dementia. 8: P68-P69. DOI: 10.1016/j.jalz.2012.05.1858  0.47
2012 Laws S, Lam C, Mondal A, Bush A, Ellis K, Macaulay L, Rowe C, Taddei K, Szoeke C, Ames D, Masters C, Martins R. Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1838  0.596
2012 Chen M, Tegg M, Avdesh A, Mondal A, Lardelli M, Verdile G, Martins R. P4-121: Analysis of insulin-degrading enzyme (IDE) expression and function in zebrafish embryos Alzheimer's & Dementia. 8: P674-P674. DOI: 10.1016/J.Jalz.2012.05.1824  0.579
2012 Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Martins R, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172  0.472
2012 Bharadwaj P, Verdile G, Caine J, Macreadie I, Martins R. A yeast model for studying intracellular clearance of beta-amyloid 42 Alzheimers & Dementia. 8: 642. DOI: 10.1016/J.Jalz.2012.05.1716  0.579
2012 Restrepo C, Saling M, Yates P, Villemagne V, Ames D, Bush A, Faux N, Martins R, Masters C, Rowe C, Szoeke C, Ellis K. The effect of vascular risk factors on cognition in older adults: Data from the AIBL study Alzheimers & Dementia. 8: 635. DOI: 10.1016/J.Jalz.2012.05.1693  0.553
2012 Yates P, Desmond P, Raniga P, Phal P, Steward C, Salvado O, Martins R, Salinas S, Ellis K, Szoeke C, Masters C, Ames D, Villemagne V, Rowe C. Incidence and Associations of Lobar Microbleeds: Results From the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (Aibl) Alzheimers & Dementia. 8: 33-33. DOI: 10.1016/J.Jalz.2012.05.1642  0.424
2012 Lim YY, Harrington K, Ellis K, Ames D, Ashwood T, Jaeger J, Lachovitzki R, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Darby D, Maruff P. The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment Alzheimers & Dementia. 8: 557. DOI: 10.1016/J.Jalz.2012.05.1500  0.393
2012 Ellis K, Lim YY, Ames D, Darby D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Maruff P. Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1499  0.575
2012 Kamer A, Ellis K, Kinsella G, Ames D, Martins R, Rowe C, Macaulay L, Szoeke C, Masters C. APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1441  0.517
2012 Raffelt D, Tournier JD, Crozier S, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O, Connelly A. Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Alzheimers & Dementia. 8: 61-61. DOI: 10.1016/J.Jalz.2012.05.142  0.489
2012 Cyarto E, Cox K, Desmond P, Ames D, Szoeke C, Salvado O, Sharman M, Ellis K, Phal P, Masters C, Rowe C, Martins R, Lautenschlager N. AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline Alzheimers & Dementia. 8: 506. DOI: 10.1016/J.Jalz.2012.05.1377  0.497
2012 Gardener S, Rainey-Smith S, Gu Y, Taddei K, Laws S, Gupta VB, Ames D, Ellis K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Clifton P, Keogh J, ... ... Martins R, et al. Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing Alzheimers & Dementia. 8: 503. DOI: 10.1016/J.Jalz.2012.05.1365  0.508
2012 Brown B, Peiffer J, Gupta VB, Taddei K, Salvado O, Villemagne V, Rainey-Smith S, Ellis K, Ames D, Rowe C, Masters C, Szoeke C, Martins R. Level of physical activity is associated with hippocampal volume in a subgroup of the AIBL cohort Alzheimers & Dementia. 8: 494. DOI: 10.1016/J.Jalz.2012.05.1341  0.389
2012 Szoeke C, Ellis K, Zhang P, Rowe C, Martins R, Masters C, Ames D. A return to clinical skills in the early diagnosis of Alzheimer's disease Alzheimers & Dementia. 8: 491. DOI: 10.1016/J.Jalz.2012.05.1331  0.495
2012 Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Martins R, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132  0.539
2012 Ellis K, Maruff P, Martins R, Masters C, McBride S, Macaulay L, Rowe C, Rainey-Smith S, Rembach A, Savage G, Szoeke C, Taddei K, Villemagne V, Zhang P, Ames D. Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1312  0.5
2012 Verdile G, Sharman M, Chen M, Nik SM, Ong D, Wijaya L, Morgan N, Lardelli M, Martins R. P3-059: The impact of cholesterol intake on expression of Alzheimer's disease-related genes in the guinea pig brain Alzheimer's & Dementia. 8: P474-P475. DOI: 10.1016/J.Jalz.2012.05.1278  0.579
2012 Lim YY, Ellis K, Ames D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Pietrzak R, Maruff P. Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults Alzheimers & Dementia. 8: 439. DOI: 10.1016/J.Jalz.2012.05.1168  0.486
2012 Rowe C, Ellis K, Brown B, Bourgeat P, Faux N, Martins R, Salvado O, Masters C, Ames D, Villemagne V. Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL Alzheimers & Dementia. 8: 433. DOI: 10.1016/J.Jalz.2012.05.1154  0.492
2012 Dore V, Fripp J, Bourgeat P, Acosta O, Zhou L, Raniga P, Martins R, Macaulay L, Ellis K, Masters C, Ames D, Villemagne V, Rowe C, Salvado O. Longitudinal analysis of cortical thickness in PiB+ and PiB- healthy elderly controls Alzheimers & Dementia. 8: 34. DOI: 10.1016/J.Jalz.2012.05.088  0.402
2012 Bourgeat P, Fripp J, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Salvado O. Longitudinal modeling of joint PiB/MRI changes in Alzheimer's disease Alzheimers & Dementia. 8: 29. DOI: 10.1016/J.Jalz.2012.05.075  0.491
2012 Bourgeat P, Salvado O, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Fripp J. Classification of Alzheimer's subject based on PiB-MR manifold learning Alzheimers & Dementia. 8: 344. DOI: 10.1016/J.Jalz.2012.05.074  0.444
2012 Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, ... ... Martins R, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064  0.508
2012 Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, ... ... Martins R, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052  0.459
2012 Bateman R, Benzinger T, Cairns N, Fagan A, Goate A, Marcus D, Storandt M, Xiong C, Buckles V, Holtzman D, Moulder K, Oliver A, Santacruz A, Fox N, Ghetti B, ... ... Martins R, et al. Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN) Alzheimers & Dementia. 8: 4. DOI: 10.1016/J.Jalz.2012.05.015  0.512
2011 Wahjoepramono EJ, Wijaya LK, Taddei K, Bates KA, Howard M, Martins G, deRuyck K, Matthews PM, Verdile G, Martins RN. Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels. Neuroendocrinology. 94: 313-22. PMID 21985789 DOI: 10.1159/000330812  0.58
2011 Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. Journal of Alzheimer's Disease : Jad. 27: 909-22. PMID 21891867 DOI: 10.3233/Jad-2011-110752  0.601
2011 Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Martins R, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243  0.496
2011 Kanyenda LJ, Verdile G, Boulos S, Krishnaswamy S, Taddei K, Meloni BP, Mastaglia FL, Martins RN. The dynamics of CD147 in Alzheimer's disease development and pathology. Journal of Alzheimer's Disease : Jad. 26: 593-605. PMID 21694447 DOI: 10.3233/Jad-2011-110584  0.58
2011 Pike KE, Ellis KA, Villemagne VL, Good N, Chételat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia. 49: 2384-90. PMID 21529702 DOI: 10.1016/J.Neuropsychologia.2011.04.012  0.694
2011 Lambert JC, Dallongeville J, Ellis KA, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters CL, Rowe CC, Szoeke C, Tzourio C, ... ... Martins R, et al. Association of plasma Aß peptides with blood pressure in the elderly. Plos One. 6: e18536. PMID 21525986 DOI: 10.1371/Journal.Pone.0018536  0.358
2011 Sohrabi HR, Weinborn M, Badcock J, Bates KA, Clarnette R, Trivedi D, Verdile G, Sutton T, Lenzo NP, Gandy SE, Martins RN. New lexicon and criteria for the diagnosis of Alzheimer's disease. The Lancet. Neurology. 10: 299-300; author repl. PMID 21435594 DOI: 10.1016/S1474-4422(11)70056-4  0.638
2011 Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology. 76: 1091-8. PMID 21422459 DOI: 10.1212/Wnl.0B013E318211C352  0.595
2011 Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O. Advances in structural and molecular neuroimaging in Alzheimer's disease. The Medical Journal of Australia. 194: S20-3. PMID 21401483 DOI: 10.5694/J.1326-5377.2011.Tb02938.X  0.498
2011 McBride SJ, Szoeke CE, Good NM, Ames D, Martins RN, Masters CL, Maruff PT, Rowe CC, Savage G, Ellis KA. A web-based normative data tool for assessing cognitive performance in healthy older Australians. The Medical Journal of Australia. 194: S12-4. PMID 21401481 DOI: 10.5694/J.1326-5377.2011.Tb02936.X  0.389
2011 Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dementia and Geriatric Cognitive Disorders. 31: 173-8. PMID 21389718 DOI: 10.1159/000325171  0.58
2011 Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain : a Journal of Neurology. 134: 798-807. PMID 21310725 DOI: 10.1093/Brain/Awq383  0.479
2011 Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Annals of Neurology. 69: 181-92. PMID 21280088 DOI: 10.1002/Ana.22248  0.452
2011 Newman M, Verdile G, Martins RN, Lardelli M. Zebrafish as a tool in Alzheimer's disease research. Biochimica Et Biophysica Acta. 1812: 346-52. PMID 20920580 DOI: 10.1016/J.Bbadis.2010.09.012  0.535
2011 Szoeke C, Ellis K, Fahey M, Zhang P, Savage G, Sohrabi H, Rowe C, Martins R, Masters C, Ames D. Healthy older adults in the AIBL cohort at risk for cognitive decline Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.018  0.444
2011 Buckley R, Saling M, Ellis K, Lautenschlager N, Maruff P, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Ames D. Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: A cross-sectional analysis Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.677  0.459
2011 Dore V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O. Cortical thickness comparison between PiB-positive and PiB-negative healthy control patients Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.591  0.375
2011 Ellis KA, Rowe C, Salvado O, Masters C, Martins R, Villemagne V, Bourgeat P, Ames D, Maruff P, Savage G, Macaulay L, Szoeke C, Yates P, Restrepo C. Normative neuropsychology datasets free from prodromal Alzheimer's disease (AD) cases may improve sensitivity for detecting early cognitive decline: Data from the AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.427  0.558
2011 Ellis KA, Rowe C, Masters C, Szoeke C, Taddei K, Martins R, Villemagne V, Fahey M, Ames D, Maruff P, Zhang P, Savage G, Macaulay L. Predictors of cognitive decline at 18 month follow up among 1112 participants in the Australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.426  0.508
2011 Rembach A, Rowe C, Ellis K, Doecke J, Masters C, Martins R, Faux N, Duce J, Ames D, Volitakis I, Bush A, Roberts B, Trounson B, Fowler C, Pertile K, et al. Plasma copper and ceruloplasmin are not altered in Alzheimer's disease: Baseline data in the Australian Imaging Biomarker Lifestyle (AIBL) study of Ageing Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.386  0.61
2011 Drummond E, Martins R, Harvey A. P1-037: Development of an Alzheimer's disease mouse model using viral vectors to cause localized over-expression of beta amyloid Alzheimer's & Dementia. 7: S122-S122. DOI: 10.1016/J.Jalz.2011.05.317  0.377
2011 Bates KA, Harvey A, Martins R, Vink R. Closed head injury in the guinea pig, a new animal model for Alzheimer's disease? Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.313  0.324
2011 Avdesh A, Martin-Iverson M, Chen M, Groth D, Mondal A, Morgan N, Lardelli M, Martins R, Verdile G. Evaluation of color preference in zebrafish: A possible potential model for learning and memory disorders Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.311  0.579
2011 Morici M, Martins I, Taddei K, Martins R, Verdile G, Wijaya L, Sharman M, Berger T. O1-03-06: Peripheral clearance of intravenously injected Aß42 is APOE genotype-specific in chow-fed mice but not cholesterol-fed mice Alzheimer's & Dementia. 7: S99-S99. DOI: 10.1016/J.Jalz.2011.05.244  0.579
2011 Rowe C, Ellis K, Brown B, Bourgeat P, Head R, Salvado O, Martins R, Masters C, Ames D, Villemagne V. The consequences of Aβ deposition in aging and Alzheimer's disease: Results from 366 elderly subjects Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2016  0.534
2011 Fagan A, Xiong C, Bateman R, Goate A, Holtzman D, Ghetti B, Martins R, Masters C, Mayeux R, Ringman J, Rossor M, Salloway S, Schofield P, Sperling R, Morris J. Plasma and Cerebrospinal Fluid Markers in the DIAN Study of Autosomal-Dominant Alzheimer’s Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1960  0.427
2011 Villemagne V, Ellis K, Chetelat G, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Aβ accumulation correlates with cognitive decline: results from the longitudinal AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.142  0.517
2011 Ellis K, Walker S, Robertson J, Mucha L, Bobula J, Martins R, Masters C, Rowe C, Szoeke C, Ames D. Dependence and resource utilization in MCI and Alzheimer’s patients participating in the AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1273  0.403
2011 Macreadie I, Verdile G, Martins R. P2-300: Targets of Aβ-induced activation of mTOR pathway in yeast model Alzheimer's & Dementia. 7: S406-S407. DOI: 10.1016/J.Jalz.2011.05.1178  0.579
2011 Chetelat G, Villain N, Villemagne V, Ames D, Ellis K, Head R, Martins R, Masters C, Rowe C. The effects of APOE4 on the rate of atrophy and Aβ deposition in asymptomatic elderly Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.106  0.471
2011 Lambert J, Dallongeville J, Ellis K, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters C, Rowe C, Szoeke C, Tzourio C, ... ... Martins R, et al. Association of plasma Amyloid Beta peptides with blood pressure in the elderly Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1027  0.425
2011 Chételat G, Villemagne V, Villain N, Jones G, Ellis K, Ames D, Martins R, Head R, Masters C, Rowe C. Greater rate of atrophy in elderly with high versus low Aβ deposition Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.051  0.451
2010 Barron AM, Verdile G, Taddei K, Bates KA, Martins RN. Effect of chronic hCG administration on Alzheimer's-related cognition and A beta accumulation in PS1KI mice. Endocrinology. 151: 5380-8. PMID 20844010 DOI: 10.1210/En.2009-1168  0.646
2010 Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain : a Journal of Neurology. 133: 3349-58. PMID 20739349 DOI: 10.1093/Brain/Awq187  0.413
2010 Bharadwaj P, Martins R, Macreadie I. Yeast as a model for studying Alzheimer's disease. Fems Yeast Research. 10: 961-9. PMID 20618869 DOI: 10.1111/J.1567-1364.2010.00658.X  0.455
2010 Newman M, Wilson L, Camp E, Verdile G, Martins R, Lardelli M. A zebrafish melanophore model of amyloid beta toxicity. Zebrafish. 7: 155-9. PMID 20515319 DOI: 10.1089/Zeb.2009.0628  0.579
2010 Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, ... ... Martins R, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging. 31: 1275-83. PMID 20472326 DOI: 10.1016/J.Neurobiolaging.2010.04.007  0.573
2010 Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 291-6. PMID 20451879 DOI: 10.1016/J.Jalz.2010.03.009  0.489
2010 Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, ... ... Martins RN, et al. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. Journal of Alzheimer's Disease : Jad. 20: 1233-42. PMID 20413897 DOI: 10.3233/Jad-2010-090249  0.591
2010 Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology. 67: 317-24. PMID 20373343 DOI: 10.1002/Ana.21955  0.472
2010 Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O, et al. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 74: 121-7. PMID 20065247 DOI: 10.1212/Wnl.0B013E3181C918B5  0.513
2010 Rodrigues MA, Foster JK, Verdile G, Joesbury K, Prince R, Devine A, Mehta P, Beilby J, Martins RN. Predicting memory decline as a risk factor for Alzheimer's disease in older post-menopausal women: quod erat demonstrandum? International Psychogeriatrics / Ipa. 22: 332-5. PMID 19814842 DOI: 10.1017/S1041610209991190  0.582
2010 Taddei K, Laws SM, Verdile G, Munns S, D'Costa K, Harvey AR, Martins IJ, Hill F, Levy E, Shaw JE, Martins RN. Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity. Neurobiology of Aging. 31: 203-14. PMID 18472186 DOI: 10.1016/J.Neurobiolaging.2008.03.023  0.598
2010 Brown BM, Peiffer JJ, Taddei K, Foster JK, Ward VK, Lachovitzki RM, Rodrigues MA, Taddei T, Lui J, Gupta V, Laws SM, Rimajova MR, Ellis KA, Szoeke C, Masters CL, ... ... Martins RN, et al. O4-07-02: Monitored physical activity is associated with better cognitive performance in the elderly: A study from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study Alzheimer's & Dementia. 6: S162-S163. DOI: 10.1016/J.Jalz.2010.05.505  0.365
2010 Villemagne VL, Chetelat G, Pike K, Jones G, Ellis K, Li Q, Mulligan R, Ackermann U, O'Keefe G, Martins R, Ames D, Masters CL, Rowe C. Comparison of biomarkers for the prediction of cognitive decline Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.431  0.458
2010 Rowe CC, Ellis K, Chetelat G, Pike K, Rimajova M, Szoeke C, Bourgeat P, Salvado O, Martins R, Masters CL, Ames D, Villemagne VL. Baseline and follow-up neuroimaging results from the Australian imaging, biomarker, and lifestyle flagship study of aging (AIBL) Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.430  0.426
2010 Doecke J, Buckley M, Good N, Laws S, Faux N, Dunne R, Wilson W, Bush A, Ames D, Ellis K, Rowe C, Szoeke C, Martins R, Masters C. Identifying protein biomarkers for early diagnosis of Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.407  0.611
2010 Foster J, Jha U, Brown B, Savage G, Ellis K, Darby D, Lautenschlager N, Maruff P, Szoeke C, Taddei K, Ward V, Rodrigues M, Lachovitzki R, Rimajova M, Lenzo N, ... ... Martins R, et al. Subjective memory complainers in the AIBL cohort: Hypervigilance amongst the worried well, or individuals at increased risk of Alzheimer's disease? Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.397  0.485
2010 Ellis KA, Clifford D, Villemagne VL, Ames D, Chetelat G, Foster J, Martins R, Maruff P, Masters CL, Szoeke C, Rowe CC. In an amnestic MCI population, those with high PIB binding perform more poorly on memory tests than those with low binding Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.309  0.389
2010 Martins RN, Gandy SE, Gupta V, Steele JW, Kim SH, Cirrito J, Lachenmayer L, Ehrlich M, Yue Z, Bharadwaj P, Barr R, Martins I, Morici M, Taddei K, Verdile G. P3-409: Effects of latrepirdine on Aβ clearance, neurotoxicity and aggregation Alzheimer's & Dementia. 6: S572-S573. DOI: 10.1016/J.Jalz.2010.05.1952  0.574
2010 Bharadwaj PR, Barr R, Lachenmayer L, Steele JW, Ehrlich ME, Yue Z, Gandy S, Verdile G, Martins R. P3-377: Latrepirdine enhances Aβ degradation in yeast via an autophagic pathway Alzheimer's & Dementia. 6: S562-S563. DOI: 10.1016/J.Jalz.2010.05.1919  0.579
2010 Gupta VB, Bhardawaj P, Steele J, Taddei K, Morici M, Gandy S, Verdile G, Martins R. P3-324: Latrepirdine modulates Aβ oligomer formation and attenuates oligomer-associated toxicity Alzheimer's & Dementia. 6: S547-S547. DOI: 10.1016/J.Jalz.2010.05.1825  0.579
2010 Faux NG, Ellis KA, Fowler CJ, Martins R, Pertile KK, Rowe C, Rumble RL, Szoeke C, Porter L, Rembach A, Trounson B, Masters C, Ames D, Bush AI. Plasma levels of homocysteine and red cell folate correlate with neurological composite z-scores in Alzheimer's disease and healthy subjects: The Australian Imaging Biomarker Lifestyle (AIBL) study of aging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1726  0.604
2010 Kotsopoulos EJ, Good N, Ames DA, Fazio DD, Forster J, Maruff P, Masters C, Martins R, O'Halloran C, Rowe C, Savage G, Szoeke C, Ellis KA. Normative data from the AIBL study: Language, visuoconstruction, and executive functioning in a large healthy elderly cohort Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1631  0.379
2010 Chetelat G, Villemagne V, Bourgeat P, Pike K, Jones G, Ames D, Ellis K, Szoeke C, Martins R, O'Keefe G, Salvado O, Masters C, Rowe C. Relationship between Atrophy and Beta-Amyloid Deposition in Normal Elderly, Mild Cognitive Impairment and Alzheimer's Disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.129  0.552
2010 Ellis KA, Bush AI, Foster J, Martins RN, Maruff P, Masters CL, Rowe CC, Savage G, Szoeke C, Ames D. P2-178: Findings from the first 18-month follow up of the Australian Imaging Biomarkers and Lifestyle (AIBL) cohort Alzheimer's & Dementia. 6: S365-S366. DOI: 10.1016/J.Jalz.2010.05.1226  0.479
2010 Kaldi A, Ellis KA, Darby D, Ames D, Martins R, Masters CL, Rowe C, Szoeke C, Maruff P. Determining rate of decline in pre-AD and AD AIBL participants using a brief computerized battery Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1143  0.502
2010 Chetelat G, Villemagne V, Pike K, Baron J, Bourgeat P, Jones G, Ellis K, Salvado O, Szoeke C, Martins R, Ames D, Masters C, Rowe C. Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.009  0.438
2009 Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. 111: 1275-308. PMID 20050287 DOI: 10.1111/J.1471-4159.2009.06408.X  0.621
2009 Krishnaswamy S, Verdile G, Groth D, Kanyenda L, Martins RN. The structure and function of Alzheimer's gamma secretase enzyme complex. Critical Reviews in Clinical Laboratory Sciences. 46: 282-301. PMID 19958215 DOI: 10.3109/10408360903335821  0.587
2009 Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho L, Fraser P, Westaway D, Hyslop PS, Martins RN, Buxbaum JD, Pasinetti GM, Dickstein DL, Hof PR, Ehrlich ME, Gandy S. Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Molecular Neurodegeneration. 4: 40. PMID 19845940 DOI: 10.1186/1750-1326-4-40  0.312
2009 Nornes S, Newman M, Wells S, Verdile G, Martins RN, Lardelli M. Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos. Experimental Cell Research. 315: 2791-801. PMID 19563801 DOI: 10.1016/J.Yexcr.2009.06.023  0.535
2009 Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics / Ipa. 21: 672-87. PMID 19470201 DOI: 10.1017/S1041610209009405  0.61
2009 Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. Journal of Cellular and Molecular Medicine. 13: 412-21. PMID 19374683 DOI: 10.1111/J.1582-4934.2009.00609.X  0.469
2009 Drummond ES, Harvey AR, Martins RN. Androgens and Alzheimer's disease. Current Opinion in Endocrinology, Diabetes, and Obesity. 16: 254-9. PMID 19373081 DOI: 10.1097/MED.0b013e32832b101f  0.331
2009 Bates KA, Sohrabi HR, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager NT, ... ... Martins RN, et al. Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers. Journal of Alzheimer's Disease : Jad. 17: 305-18. PMID 19363264 DOI: 10.3233/Jad-2009-1050  0.339
2009 Barron AM, Cake M, Verdile G, Martins RN. Ovariectomy and 17beta-estradiol replacement do not alter beta-amyloid levels in sheep brain. Endocrinology. 150: 3228-36. PMID 19282379 DOI: 10.1210/En.2008-1252  0.579
2009 Foster JK, Verdile G, Bates KA, Martins RN. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential? Molecular Psychiatry. 14: 239-51. PMID 18957942 DOI: 10.1038/Mp.2008.115  0.644
2009 Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Molecular Psychiatry. 14: 469-86. PMID 18794889 DOI: 10.1038/Mp.2008.96  0.703
2009 Bates KA, Verdile G, Li Q, Ames D, Hudson P, Masters CL, Martins RN. Erratum: Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests Molecular Psychiatry. 14: 1144-1144. DOI: 10.1038/Mp.2008.123  0.636
2009 Foster JK, Ellis K, Savage G, Darby D, Lautenschlager N, Maruff P, Taddei K, Ward V, Rodrigues M, Brown B, Rimajova M, Taddei T, Lui J, Masters C, Martins R, et al. O4-05-06: Neuropsychological performance and the e4 and e2 alleles: Findings from the first phase of the australian imaging, biomarker and lifestyle (AIBL) flagship study of ageing Alzheimer's & Dementia. 5: P160-P161. DOI: 10.1016/J.Jalz.2009.05.554  0.402
2009 Ellis K, Rowe C, Masters C, Martins R, Hudson P, Milner A, Bevege L, Ames D. Baseline data from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing Alzheimer's & Dementia. 5: e4-e4. DOI: 10.1016/J.Jalz.2009.05.265  0.326
2009 Ames DJ, Maruff P, Savage G, Foster J, Darby D, Pike K, Kotsopoulos E, De Fazio D, Rowe C, Szoeke C, Masters C, Martins R, Hudson P, Milner A, Ellis KA. IC-P-022: The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? Alzheimer's & Dementia. 5: P14-P14. DOI: 10.1016/J.Jalz.2009.05.042  0.45
2009 Szoeke C, Ellis KA, Bush A, Darby D, Fazio DD, Foster J, Hudson P, Lautenschlager N, Lenzo N, Martins R, Maruff P, Masters C, Milner A, Pike K, Rowe C, et al. The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers Alzheimers & Dementia. 5: 10. DOI: 10.1016/J.Jalz.2009.05.033  0.53
2009 Lui J, Ruyck KD, Gupta V, Li Q, Taddei K, Foster J, Taddei T, Brown B, Ward V, Rodrigues M, Ellis K, Rowe C, Villemagne V, Hudson P, Masters C, ... Martins R, et al. Amyloid-β and its relevance to the detection of Alzheimer's disease in blood plasma: Findings from the first phase of the Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of ageing Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.1196  0.512
2009 Wijaya LK, Wahjoepramono EJ, Taddei K, Martins G, Howard M, Bates K, Dhaliwal S, Verdile G, Martins R. P1-029: Effect of cortical placement of luteinizing hormone on Aβ metabolism in guinea pigs Alzheimer's & Dementia. 5: P180-P180. DOI: 10.1016/J.Jalz.2009.04.032  0.579
2008 Chan HW, Liu T, Verdile G, Bishop G, Haasl RJ, Smith MA, Perry G, Martins RN, Atwood CS. Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. International Journal of Clinical and Experimental Medicine. 1: 76-88. PMID 19079689  0.579
2008 Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G, Howard M, de Ruyck K, Bates K, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. Journal of Alzheimer's Disease : Jad. 15: 129-37. PMID 18780973 DOI: 10.3233/Jad-2008-15111  0.586
2008 Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, ... ... Martins RN, et al. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation. 5: 36. PMID 18715507 DOI: 10.1186/1742-2094-5-36  0.623
2008 Verdile G, Yeap BB, Clarnette RM, Dhaliwal S, Burkhardt MS, Chubb SA, De Ruyck K, Rodrigues M, Mehta PD, Foster JK, Bruce DG, Martins RN. Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. Journal of Alzheimer's Disease : Jad. 14: 201-8. PMID 18560131 DOI: 10.3233/Jad-2008-14208  0.617
2008 Rodrigues MA, Verdile G, Foster JK, Hogervorst E, Joesbury K, Dhaliwal S, Corder EH, Laws SM, Hone E, Prince R, Devine A, Mehta P, Beilby J, Atwood CS, Martins RN. Gonadotropins and cognition in older women. Journal of Alzheimer's Disease : Jad. 13: 267-74. PMID 18430994 DOI: 10.3233/Jad-2008-13304  0.586
2008 Foster J, Sohrabi H, Verdile G, Martins R. Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatrics / Ipa. 20: 853-5. PMID 18416874 DOI: 10.1017/S1041610208006807  0.605
2008 Nornes S, Newman M, Verdile G, Wells S, Stoick-Cooper CL, Tucker B, Frederich-Sleptsova I, Martins R, Lardelli M. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Human Molecular Genetics. 17: 402-12. PMID 17981814 DOI: 10.1093/Hmg/Ddm317  0.579
2008 Bates KA, Sohrabi HR, Rodrigues M, De Ruyck K, Beilby J, Dhaliwal SS, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager NT, ... ... Martins RN, et al. P1-342: Relationship between cardiovascular disease risk factors and Alzheimer's disease Aβ protein in subjective memory complainers Alzheimer's & Dementia. 4: T319-T319. DOI: 10.1016/J.Jalz.2008.05.923  0.353
2008 Ellis KA, Rowe CC, Masters CL, Martins RN, Hudson P, Milner A, Bevege L, Savage G, Ames D. P2-006: Baseline data from a multi-centre, prospective longitudinal study of ageing in 1000 volunteers (the AIBL study) Alzheimer's & Dementia. 4: T367-T367. DOI: 10.1016/J.Jalz.2008.05.1086  0.305
2008 Barron AM, Taddei K, DeRuyck K, Croft KD, Mori TA, Verdile G, Martins RN. P1-436: Time- and dose-dependent effects of ovariectomy and human chorionic gonadotropin treatment on beta amyloid and isoprostane levels in the PS1M146V mouse model of Alzheimer's disease Alzheimer's & Dementia. 4: T347-T347. DOI: 10.1016/J.Jalz.2008.05.1018  0.535
2008 Ellis KA, Villemagne VL, Ames D, Lenzo N, Pike KE, O'Keefe G, Tochon-Danguy H, Price R, Jones G, Rimajova M, Bourgeat P, Raniga P, Fripp J, Acosta O, Salvado O, ... Martins R, et al. IC-03-03: The Australian Biomarker, Imaging and Lifestyle Study: Preliminary PIB results Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.008  0.371
2007 McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process. Experimental Gerontology. 42: 355-63. PMID 17140756 DOI: 10.1016/j.exger.2006.10.015  0.301
2007 Verdile G, Gandy SE, Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochemical Research. 32: 609-23. PMID 16944319 DOI: 10.1007/S11064-006-9131-X  0.579
2006 Ellis K, Ames D, Martins R, Hudson P, Masters C. The Australian Biomarkers Lifestyle and Imaging flagship study of ageing. Acta Neuropsychiatrica. 18: 285. PMID 27397271 DOI: 10.1017/S0924270800031136  0.322
2006 Barron AM, Fuller SJ, Verdile G, Martins RN. Reproductive hormones modulate oxidative stress in Alzheimer's disease. Antioxidants & Redox Signaling. 8: 2047-59. PMID 17034349 DOI: 10.1089/Ars.2006.8.2047  0.535
2006 Martins IJ, Hone E, Foster JK, Sünram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Molecular Psychiatry. 11: 721-36. PMID 16786033 DOI: 10.1038/Sj.Mp.4001854  0.41
2006 Barron AM, Verdile G, Martins RN. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. Endocrine. 29: 257-69. PMID 16785601 DOI: 10.1385/Endo:29:2:257  0.535
2006 Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiology of Aging. 27: 228-36. PMID 15894409 DOI: 10.1016/J.Neurobiolaging.2005.01.018  0.408
2006 Martins RN, Balakrishnan K, Verdile G, Bates K, Mehta PD, Beilby J, Nolan D, Galvao D, Gandy SE. P1-167: Plasma Aβ42 correlates positively with increased body fat Alzheimer's & Dementia. 2: S144-S145. DOI: 10.1016/J.Jalz.2006.05.543  0.549
2005 Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Galvão DA, Newton R, Gandy SE, Martins RN. Plasma Abeta42 correlates positively with increased body fat in healthy individuals. Journal of Alzheimer's Disease : Jad. 8: 269-82. PMID 16340084 DOI: 10.3233/Jad-2005-8305  0.61
2005 Lautenschlager NT, Wu JS, Laws SM, Almeida OP, Clarnette RM, Joesbury K, Wagenpfeil S, Martins G, Paton A, Gandy SE, Förstl H, Martins RN. Neurological soft signs are associated with APOE genotype, age and cognitive performance. Journal of Alzheimer's Disease : Jad. 7: 325-30. PMID 16131735 DOI: 10.3233/Jad-2005-7409  0.368
2005 Hone E, Martins IJ, Jeoung M, Ji TH, Gandy SE, Martins RN. Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding. Journal of Alzheimer's Disease : Jad. 7: 303-14. PMID 16131732 DOI: 10.3233/Jad-2005-7406  0.398
2005 Bates KA, Harvey AR, Carruthers M, Martins RN. Androgens, andropause and neurodegeneration: Exploring the link between steroidogenesis, androgens and Alzheimer's disease Cellular and Molecular Life Sciences. 62: 281-292. PMID 15723164 DOI: 10.1007/S00018-004-4383-1  0.383
2005 Bowen RL, Martins RN, Gregory CW, Smith MA, Atwood CS. Dementia and testosterone levels in men. Jama. 293: 551; author reply 55. PMID 15687304 DOI: 10.1001/Jama.293.5.551-B  0.352
2004 Carter TL, Verdile G, Groth D, Bogush A, Thomas S, Shen P, Fraser PE, Mathews P, Nixon RA, Ehrlich ME, Kwok JB, St George-Hyslop P, Schofield P, Li Y, Yang A, ... Martins RN, et al. Alzheimer amyloid precursor aspartyl proteinase activity in CHAPSO homogenates of Spodoptera frugiperda cells. Alzheimer Disease and Associated Disorders. 18: 261-3. PMID 15592142  0.577
2004 Verdile G, Gnjec A, Miklossy J, Fonte J, Veurink G, Bates K, Kakulas B, Mehta PD, Milward EA, Tan N, Lareu R, Lim D, Dharmarajan A, Martins RN. Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology. 63: 1385-92. PMID 15505153 DOI: 10.1212/01.Wnl.0000141848.45315.A6  0.662
2004 Sweeney D, Martins R, LeVine H, Smith JD, Gandy S. Similar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoforms. Journal of Neuroinflammation. 1: 15. PMID 15312232 DOI: 10.1186/1742-2094-1-15  0.32
2004 Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 50: 397-409. PMID 15304237 DOI: 10.1016/J.Phrs.2003.12.028  0.614
2004 Burkhardt MS, Foster JK, Laws SM, Baker LD, Craft S, Gandy SE, Stuckey BG, Clarnette R, Nolan D, Hewson-Bower B, Martins RN. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. Journal of Alzheimer's Disease : Jad. 6: 221-8. PMID 15201477 DOI: 10.3233/Jad-2004-6302  0.366
2004 Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. The Journal of Biological Chemistry. 279: 20539-45. PMID 14871891 DOI: 10.1074/Jbc.M311993200  0.652
2004 Liu T, Perry G, Chan HW, Verdile G, Martins RN, Smith MA, Atwood CS. Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. Journal of Neurochemistry. 88: 554-63. PMID 14720205 DOI: 10.1046/J.1471-4159.2003.02196.X  0.625
2004 Lim D, Flicker L, Dharamarajan A, Martins RN. Can testosterone replacement decrease the memory problem of old age? Medical Hypotheses. 60: 893-6. PMID 12699720 DOI: 10.1016/S0306-9877(03)00072-0  0.336
2004 Verdile G, Groth D, Mathews P, George-Hyslop PS, Fraser P, Ramabhadran T, Kwok J, Schofield P, Carter T, Gandy S, Martins R. P4-265 Baculoviral expressionof the presenilin mutation lacking exon 9 increase levels of an amyloid beta — like protein in SF9insect cells Neurobiology of Aging. 25: S550-S551. DOI: 10.1016/S0197-4580(04)81823-2  0.598
2004 Atwood CS, Liu T, Smith MA, Martins RN, Bowen RL, Verdile G. O2-04-06 17β-Estradiol and luteinizing hormone modulate the expression of luteinizing hormone receptors in neuroblastoma cells Neurobiology of Aging. 25: S40. DOI: 10.1016/S0197-4580(04)80132-5  0.564
2003 Veurink G, Fuller SJ, Atwood CS, Martins RN. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease. Annals of Human Biology. 30: 639-67. PMID 14675907 DOI: 10.1080/03014460310001620144  0.351
2003 Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Research. Brain Research Reviews. 43: 1-16. PMID 14499458 DOI: 10.1016/S0165-0173(03)00174-7  0.395
2003 Dean B, Laws SM, Hone E, Taddei K, Scarr E, Thomas EA, Harper C, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biological Psychiatry. 54: 616-22. PMID 13129656 DOI: 10.1016/S0006-3223(03)00075-1  0.333
2003 Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard F, Mehta PD, McLean CA, Masters CL, Brooks WS, Martins RN. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease. Neurobiology of Aging. 24: 655-62. PMID 12885573 DOI: 10.1016/S0197-4580(02)00192-6  0.646
2003 Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biological Psychiatry. 54: 136-41. PMID 12873803 DOI: 10.1016/S0006-3223(02)01976-5  0.48
2003 Sumioka A, Imoto S, Martins RN, Kirino Y, Suzuki T. XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms. The Biochemical Journal. 374: 261-8. PMID 12780348 DOI: 10.1042/Bj20030489  0.358
2003 Veurink G, Liu D, Taddei K, Perry G, Smith MA, Robertson TA, Hone E, Groth DM, Atwood CS, Martins RN. Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radical Biology & Medicine. 34: 1070-7. PMID 12684092 DOI: 10.1016/S0891-5849(03)00042-X  0.36
2003 Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J. Early olfactory involvement in Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: 20-5. PMID 12619779 DOI: 10.1017/S0317167100002389  0.349
2002 Sparks DL, Martins R, Martin T. Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related Differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits. Annals of the New York Academy of Sciences. 977: 356-66. PMID 12480773 DOI: 10.1111/J.1749-6632.2002.Tb04838.X  0.337
2002 Bowen RL, Smith MA, Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. Journal of Neuroscience Research. 70: 514-8. PMID 12391612 DOI: 10.1002/Jnr.10452  0.418
2002 Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. Molecular Psychiatry. 7: 886-90. PMID 12232782 DOI: 10.1038/Sj.Mp.4001097  0.404
2002 Bates KA, Fonte J, Robertson TA, Martins RN, Harvey AR. Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein. Neuroscience. 113: 785-96. PMID 12182886 DOI: 10.1016/S0306-4522(02)00230-0  0.358
2002 Atwood CS, Martins RN, Smith MA, Perry G. Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides. 23: 1343-50. PMID 12128091 DOI: 10.1016/S0196-9781(02)00070-0  0.384
2002 Fodero LR, Sáez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. Journal of Neurochemistry. 81: 441-8. PMID 12065653 DOI: 10.1046/J.1471-4159.2002.00902.X  0.4
2001 Fonte J, Miklossy J, Atwood C, Martins R. The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-beta Levels: Resolubilization of amyloid-beta with transition metal ion chelators. Journal of Alzheimer's Disease : Jad. 3: 209-219. PMID 12214062 DOI: 10.3233/Jad-2001-3206  0.422
2000 Kok CC, Boyt A, Gaudieri S, Martins R, Askanas V, Dalakas M, Kiers L, Mastaglia F, Garlepp M. Mitochondrial DNA variants in inclusion body myositis. Neuromuscular Disorders. 10: 604-611. PMID 11053689 DOI: 10.1016/S0960-8966(00)00144-9  0.337
2000 Verdile G, Martins RN, Duthie M, Holmes E, St George-Hyslop PH, Fraser PE. Inhibiting amyloid precursor protein C-terminal cleavage promotes an interaction with presenilin 1. The Journal of Biological Chemistry. 275: 20794-8. PMID 10801777 DOI: 10.1074/Jbc.C000208200  0.535
2000 Boyt AA, Taddei TK, Hallmayer J, Helmerhorst E, Gandy SE, Craft S, Martins RN. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience. 95: 727-34. PMID 10670439 DOI: 10.1016/S0306-4522(99)00458-3  0.353
1999 Miklossy J, Taddei K, Martins R, Escher G, Kraftsik R, Pillevuit O, Lepori D, Campiche M. Alzheimer disease: curly fibers and tangles in organs other than brain. Journal of Neuropathology and Experimental Neurology. 58: 803-14. PMID 10446805 DOI: 10.1097/00005072-199908000-00003  0.386
1999 Yang DS, Small DH, Seydel U, Smith JD, Hallmayer J, Gandy SE, Martins RN. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience. 90: 1217-26. PMID 10338292 DOI: 10.1016/S0306-4522(98)00561-2  0.316
1992 Moir RD, Martins RN, Bush AI, Small DH, Milward EA, Rumble BA, Multhaup G, Beyreuther K, Masters CL. Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization. Journal of Neurochemistry. 59: 1490-8. PMID 1402900 DOI: 10.1111/J.1471-4159.1992.Tb08465.X  0.559
1989 Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. The New England Journal of Medicine. 320: 1446-52. PMID 2566117 DOI: 10.1056/Nejm198906013202203  0.517
1988 Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology. 38: 1688-93. PMID 3054625 DOI: 10.1212/Wnl.38.11.1688  0.513
1986 Martins RN, Harper CG, Stokes GB, Masters CL. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. Journal of Neurochemistry. 46: 1042-5. PMID 3950618 DOI: 10.1111/j.1471-4159.1986.tb00615.x  0.358
1985 Masters C, Multhaup G, Simms G, Pottgiesser J, Martins R, Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. The Embo Journal. 4: 2757-2763. DOI: 10.1002/J.1460-2075.1985.Tb04000.X  0.438
Show low-probability matches.